Leiomyoma of uterus

CD2_BENIGN_LEIOMYOMA_UTERI_EXALLC

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data
1. Apply sex-specific rule only females	-
2. Check conditions None
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — D25 Hospital discharge: ICD-9 — 218 Hospital discharge: ICD-8 — 21899 Cause of death: ICD-10 — D25 Cause of death: ICD-9 — 218 Cause of death: ICD-8 — 21899 2 out of 7 registries used, show all original rules.	-
4. Check minimum number of events None	-
5. Include endpoints None	-
6. Filter based on genotype QC (FinnGen only) None	-

Control definitions (FinnGen only)

Control exclude: C3_CANCER, C3_CANCER_WIDE

Extra metadata

Level in the ICD hierarchy: 2
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: D10-D36
Name in latin: Leiomyoma uteri

NAME	CD2_BENIGN_LEIOMYOMA_UTERI_EXALLC
CONTROL_EXCLUDE	C3_CANCER\|C3_CANCER_WIDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX	2
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	D25
HD_ICD_9	218
HD_ICD_8	21899
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	D25
COD_ICD_9	218
COD_ICD_8	21899
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Leiomyoma of uterus based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

No upset plot: script not run.

No upset table: script not run.

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	43521	43521	-
Unadjusted period prevalence (%)	14.83	14.83	-
Median age at first event (years)	46.68	46.68	-

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
6468: Matched controls
46868

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

LCA06

NOMESCO Finland

Biopsy of endometrium

5.9

323.0

2356

4154

D25.0

ICD-10 Finland

Submucous leiomyoma of uterus

365.0

323.0

1611

B02AA02

ATC

tranexamic acid; systemic

3.8

323.0

2261

5793

D25.1

ICD-10 Finland

Intramural leiomyoma of uterus

133.5

323.0

2229

184

LCD00

NOMESCO Finland

Hysterectomy

23.2

323.0

533

181

LCD01

NOMESCO Finland

Total laparoscopic hysterectomy

11.7

323.0

773

537

LBE20

NOMESCO Finland

Laparoscopic bilateral salpingectomy

13.5

323.0

736

440

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

3.3

323.0

4097

16262

D25.2

ICD-10 Finland

Subserosal leiomyoma of uterus

165.8

323.0

923

N92.0

ICD-10 Finland

Excessive and frequent menstruation with regular cycle

4.0

323.0

2099

5038

D25.9

ICD-10 Finland

Leiomyoma of uterus, unspecified

323.0

4077

246

LCB14

NOMESCO Finland

Laparoscopic myolysis

99.3

323.0

447

LCD04

NOMESCO Finland

Laparoscopic hysterectomy

10.7

323.0

758

576

G03XB02

ATC

ulipristal; oral (progesterone receptor modulators)

243.4

252.9

291

N92.1

ICD-10 Finland

Excessive and frequent menstruation with irregular cycle

3.6

228.1

1245

2905

D25

ICD-10 Finland

Leiomyoma of uterus

18.5

220.5

379

157

115

Kela drug reimbursment

Breast cancer

+∞

218.8

237

LCB10

NOMESCO Finland

Myomectomy

146.7

212.8

253

LCB11

NOMESCO Finland

Laparoscopic myomectomy

341.1

201.0

228

LBE01

NOMESCO Finland

Laparoscopic salpingectomy

4.8

184.7

705

1161

TLC00

NOMESCO Finland

Insertion of intrauterine device

2.8

171.1

1408

4298

LC2HE

NOMESCO Finland

Hystero-salpingography with ultrasound

3.5

169.8

938

2166

LCB25

NOMESCO Finland

Hysteroscopic excision of lesion

4.7

162.4

630

1050

PJA12

NOMESCO Finland

Sentinel node biopsy

87.9

160.5

200

WX402

NOMESCO Finland

General anaesthesia

2.8

158.7

1253

3706

LC2DE

NOMESCO Finland

Demanding ultrsound examination of uterus, parametrium and lower part of abdomen with speciel methods

3.7

158.5

810

1749

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.4

151.4

1586

5499

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

+∞

141.8

154

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

2.4

136.8

1458

5061

LCD97

NOMESCO Finland

Other laparoscopic hysterectomy

134.6

136.1

163

N84.0

ICD-10 Finland

Polyp of corpus uteri

3.6

129.6

684

1504

C50.41

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor

+∞

126.1

137

H02AB02

ATC

dexamethasone; systemic

9.5

116.0

265

210

L02BA01

ATC

tamoxifen; oral

34.4

112.2

162

21899

ICD-8 Finland

Uterine fibroma

+∞

107.6

117

A04AA55

ATC

palonosetron, combinations; systemic

441.9

106.6

120

O34.1

ICD-10 Finland

Maternal care for tumour of corpus uteri

12.4

105.4

210

126

N02BE01

ATC

paracetamol; systemic, rectal

2.0

102.9

5344

32915

ZXE10

NOMESCO Finland

More than one and less than three hours

1.9

102.9

2044

9098

B01AB05

ATC

enoxaparin; parenteral

2.1

102.6

1420

5473

HA003

NOMESCO Finland

Radiotherapy after partial ablation of mammary gland

177.1

102.3

120

LBE00

NOMESCO Finland

Salpingectomy

11.0

98.3

207

140

LCD10

NOMESCO Finland

Vaginal hysterectomy

5.2

96.6

336

490

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

266.3

95.0

109

A04AA02

ATC

granisetron; systemic, transdermal

51.3

93.5

125

WX302

NOMESCO Finland

Thoracal epidural anesthesy

5.7

90.1

290

385

L03AA13

ATC

pegfilgrastim; parenteral

727.7

89.0

HAC20

NOMESCO Finland

Total mastectomy

75.8

81.4

103

8500/3-C50.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of breast, NOS

+∞

79.9

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.5

77.4

713

2231

PJD52

NOMESCO Finland

Block dissection of axillary lymph nodes

322.0

77.4

B01AB10

ATC

tinzaparin; parenteral

4.3

76.6

316

551

ULC02

NOMESCO Finland

Hysteroscopy

2.8

73.3

541

1485

Z36.3

ICD-10 Finland

Antenatal screening for malformations using ultrasound and other physical methods

0.6

73.2

2066

20485

N83.2

ICD-10 Finland

Other and unspecified ovarian cysts

2.0

72.6

1112

4391

WX408

NOMESCO Finland

General anesthesy, balanced

1.8

72.2

1469

6438

LX1XE

NOMESCO Finland

Other gynecological ultrasound examination

3.9

71.9

333

647

O80.0

ICD-10 Finland

Spontaneous vertex delivery

0.6

69.8

2619

24481

N92.4

ICD-10 Finland

Excessive bleeding in the premenopausal period

3.1

69.4

421

1014

YG1BD

NOMESCO Finland

Extensive CT examination of thorax for dose design of radiotherapy

288.4

69.2

MA2HE

NOMESCO Finland

Detailed morfological ultrasound examination of fetus

0.6

68.7

1176

13213

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

39.2

68.6

JN2CG

NOMESCO Finland

Extensive MRI examination of lower part of abdoment with high intensity magnet

7.4

68.4

180

181

LBE10

NOMESCO Finland

Bilateral salpingectomy

59.5

68.2

LAF11

NOMESCO Finland

Laparoscopic bilateral salpingo-oophorectomy

5.5

65.4

214

290

ZXE20

NOMESCO Finland

More than three and less than five hours

2.5

63.4

577

1783

130

Kela drug reimbursment

Malignant tumour

+∞

63.4

SPAT1197

SPAT

Extensive health check-up of expecting family

0.5

56.6

634

8063

TLC02

NOMESCO Finland

Simple extraction of IUD

2.2

56.3

634

2176

C73.91

ICD-10 Finland

Papillary carcinoma of the thyroid gland (thyroid gland)

+∞

56.0

Z34.8

ICD-10 Finland

Supervision of other normal pregnancy

0.6

55.8

1115

12195

W78

ICPC

Pregnancy

0.5

55.2

758

9119

2180A

ICD-9 Finland

Uterine leiomyoma, Submucous leiomyoma of uterus

+∞

55.1

8500/3-C50.4

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast

+∞

55.1

N80.1

ICD-10 Finland

Endometriosis of ovary

2.5

53.4

481

1475

XLD00

NOMESCO Finland

Sytologyspecimen from mouth of uterus

1.7

53.1

1297

5944

8090/3-C44.9

ICD-O-3

Basal cell carcinoma, NOS, of skin, NOS

+∞

52.3

MAX99

NOMESCO Finland

Assistance to normal delivery

0.5

52.2

547

7110

JN2DG

NOMESCO Finland

Very extensive MRI examination of lower part of abdoment with high intensity magnet

9.1

51.8

119

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

1.7

51.3

1273

5853

N80.3

ICD-10 Finland

Endometriosis of pelvic peritoneum

2.4

51.2

500

1597

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.9

51.1

234

450

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

216.8

51.0

Z09.0

ICD-10 Finland

Follow-up examination after surgery for other conditions

2.1

50.7

650

2358

ZXD10

NOMESCO Finland

Scheduled procedure

1.5

49.8

2111

11171

HAB40

NOMESCO Finland

Wedge excision of mammary gland

13.5

49.5

C50

ICD-10 Finland

Malignant neoplasm of breast

209.2

49.2

WB203

NOMESCO Finland

Simple adjuvant hormone therapy of malignancy

+∞

48.6

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.6

47.9

1716

8696

D39.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Uterus

14.5

47.2

MA2AE

NOMESCO Finland

Ultrasound examination of pregnancy (at 12. week of gestaion or later) including basic examination of fetus

0.6

46.7

1143

12040

A04AD12

ATC

aprepitant; systemic

102.3

45.9

C50.99

ICD-10 Finland

Breast, unspecified

+∞

45.9

Z39.2

ICD-10 Finland

Routine postpartum follow-up

0.6

45.4

792

9031

HA013

NOMESCO Finland

Radiotherapy after total ablation of mammary gland

+∞

45.0

8260/3-C73.9

ICD-O-3

Papillary adenocarcinoma, NOS, of thyroid gland

+∞

45.0

WF003

NOMESCO Finland

Adjuvant radiotherapy

69.4

44.8

R19.0

ICD-10 Finland

Intra-abdominal and pelvic swelling, mass and lump

4.4

44.2

177

300

L01BC06

ATC

capecitabine; oral

+∞

44.0

C50.21

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor

+∞

42.2

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.5

41.6

1989

10710

HA1AA

NOMESCO Finland

X-ray mammography

2.8

41.5

297

796

HAB50

NOMESCO Finland

Partial excision of mammary gland with reconstructive operation

29.7

41.4

SPAT1196

SPAT

Monitoring of normal pregnancy

0.5

41.3

370

5069

LCB98

NOMESCO Finland

Other transluminal endoscopic excision of lesion of uterus

4.9

41.0

146

219

N92.6

ICD-10 Finland

Irregular menstruation, unspecified

1.8

39.9

792

3369

JN4BD

NOMESCO Finland

Extensive body CT

3.6

39.8

200

417

LDA00

NOMESCO Finland

Dilatation of cervix uteri

5.2

39.4

133

188

N80.0

ICD-10 Finland

Endometriosis of uterus

2.7

38.9

288

786

C50.81

ICD-10 Finland

Overall malignant tumor of the mammary gland, ductal tumor

+∞

38.5

L03AA14

ATC

lipegfilgrastim; parenteral

+∞

38.5

Z34.0

ICD-10 Finland

Supervision of normal first pregnancy

0.6

38.2

891

9562

X76

ICPC

Malignant neoplasm breast female

+∞

37.6

LCD11

NOMESCO Finland

Laparoscopically assisted vaginal hysterectomy

9.2

36.6

MA2JE

NOMESCO Finland

Ultrasound screening of fetal nuchal translucency

0.6

36.1

481

5910

SPAT1380

SPAT

Postpartum check-up

0.5

35.8

392

5083

JN4AD

NOMESCO Finland

Body CT examination

4.9

35.7

126

188

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

49.1

35.3

Z30.4

ICD-10 Finland

Surveillance of contraceptive drugs

0.4

35.2

199

3184

128

Kela drug reimbursment

Cancers of female genital organs

102.1

34.5

ZX090

NOMESCO Finland

Other technic of radiotherapy

47.9

34.4

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

2.4

34.4

324

1015

SPAT1379

SPAT

Health check-up of pregnant person

0.6

34.3

501

6015

WX704

NOMESCO Finland

Intubation

2.1

34.1

423

1504

LAF10

NOMESCO Finland

Bilateral salpingo-oophorectomy

7.4

33.8

JAP01

NOMESCO Finland

Laparoscopic freeing of adhesions in the peritoneal cavity

3.4

33.7

179

391

P01AB01

ATC

metronidazole; oral, rectal

1.4

33.2

2675

15751

SPAT1308

SPAT

Sexual health counselling

0.6

33.0

692

7637

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

+∞

33.0

HAE10

NOMESCO Finland

Reconstruction of breast using graft or flap

17.8

33.0

L03AA02

ATC

filgrastim; parenteral

22.3

32.9

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

52.3

32.6

WX307

NOMESCO Finland

Obstetric epidural analgesia

0.5

32.6

382

4867

PD2DT

NOMESCO Finland

Embolisation of gynekological tumor

260.9

31.5

X78

ICPC

Fibromyoma uterus

35.6

31.2

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

43.7

31.0

LAF01

NOMESCO Finland

Laparoscopic unilateral salpingo-oophorectomy

2.5

30.9

257

753

I10

ICD-10 Finland

Essential (primary) hypertension

1.5

30.8

1360

7109

Z3232

NOMESCO Finland

Midwife

0.6

29.6

637

7007

D05.1

ICD-10 Finland

Intraductal carcinoma in situ

25.3

29.5

C50.49

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology

+∞

29.3

WX321

NOMESCO Finland

Acute spinal anesthesia for delivery

0.4

29.2

151

2496

M01AE01

ATC

ibuprofen; systemic, rectal

1.6

28.7

5903

40521

HAE20

NOMESCO Finland

Reconstruction of areola and mamilla using graft or flap

26.1

28.5

C50.51

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor

+∞

27.5

LAF00

NOMESCO Finland

Unilateral salpingo-oophorectomy

4.3

27.5

109

185

ZX080

NOMESCO Finland

Image guided radiotherapy

31.6

27.0

C44.51

ICD-10 Finland

Basocellular carcinoma of the skin on the torso

227.2

27.0

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

3.0

26.8

163

394

XX3DW

NOMESCO Finland

Time consuming IT work

2.4

26.7

236

716

PJ5AN

NOMESCO Finland

Localisation of sentinell lymphnode with isotope imaging

51.0

26.6

HA6AA

NOMESCO Finland

Extra corporeal mammography of operated mammary gland

5.8

26.5

103

LCA10

NOMESCO Finland

Curettage of body of uterus

2.5

26.2

229

690

W11

ICPC

Contraception oral

0.5

26.1

304

3891

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.9

25.9

437

1751

8500/2-C50.9

ICD-O-3

Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS

+∞

25.7

HA1DG

NOMESCO Finland

Very extensive MRI examination of mammary gland with high intensity magnet

10.0

25.7

LCA13

NOMESCO Finland

Curettage of cervix and body of uterus

2.6

25.5

205

591

TPH04

NOMESCO Finland

Cathetrisation of vein

1.6

25.4

845

4123

WX725

NOMESCO Finland

Noninvasive ventilation

2.4

25.2

232

718

TQW20

NOMESCO Finland

Tatoe

18.0

25.0

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

41.3

24.9

WF049

NOMESCO Finland

Radiotherapy of metastasis

+∞

24.8

W12

ICPC

Contraception intrauterine

0.7

23.9

689

7168

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

2.9

23.9

156

397

C50.40

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication

+∞

23.8

C50.90

ICD-10 Finland

Malignant tumor in other or unspecified location in mammary gland without histology

+∞

23.8

Z37.0

ICD-10 Finland

Single live birth

0.7

23.8

758

7742

N95.1

ICD-10 Finland

Menopausal and female climacteric states

1.5

23.5

851

4230

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.8

23.4

160

419

JN2BG

NOMESCO Finland

MRI examination of lower part of abdoment with high intensity magnet

5.6

23.3

1CD02

NOMESCO Finland

+∞

22.9

D39.10

ICD-10 Finland

Tumor of uncertain or unknown nature in the ovary without histology

2.8

22.7

153

397

O81.4

ICD-10 Finland

Vacuum extractor delivery

0.6

22.0

373

4351

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.9

22.0

329

1263

Z34.9

ICD-10 Finland

Supervision of normal pregnancy, unspecified

0.7

21.4

851

8379

SPAT1190

SPAT

Insertion or removal of intrauterine contraceptive device

0.6

21.4

365

4255

YG1AD

NOMESCO Finland

CT examination of thorax for dose design of radiotherapy

94.6

21.4

N02AX02

ATC

tramadol; systemic, rectal

1.3

21.1

1808

10532

WB401

NOMESCO Finland

Simple antibody therapy of primary tumour

+∞

21.1

L02BG06

ATC

exemestane; oral

+∞

21.1

C54.11

ICD-10 Finland

Adenocarcinoma of the endometrium

+∞

21.1

WB121

NOMESCO Finland

Demanding neoadjuvant cytostatic therapy

+∞

21.1

ZXC40

NOMESCO Finland

Use of ultrasound

6.1

21.0

C08CA01

ATC

amlodipine; oral

1.6

20.3

663

3213

W90

ICPC

Uncompl labour/delivery livebirth

0.5

20.3

148

2179

C50.42

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor

+∞

20.2

N93.9

ICD-10 Finland

Abnormal uterine and vaginal bleeding, unspecified

2.2

19.7

213

715

HA1AT

NOMESCO Finland

Biopsy of mammary glands with ultrasound guidance

3.6

19.7

198

HA4AT

NOMESCO Finland

Labeling mammary gland pathology with ultrasound guidance

4.4

19.7

127

NK6AN

NOMESCO Finland

Total body bone isotope imaging

19.4

19.7

C50.31

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor

+∞

19.3

MAE00

NOMESCO Finland

Outlet vacuum delivery

0.6

19.1

307

3631

ZXA10

NOMESCO Finland

Bilateral

1.5

19.0

702

3496

A02BC02

ATC

pantoprazole; systemic

1.3

19.0

3220

20513

S18

ICPC

Laceration/cut

1.3

18.7

1503

8639

Z34

ICD-10 Finland

Supervision of normal pregnancy

0.5

18.7

197

2595

D44.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Thyroid gland

4.0

18.5

142

EP1AE

NOMESCO Finland

Neck ultrasound examination

2.1

18.5

224

789

X06

ICPC

Menstruation excessive

2.2

18.4

189

619

6500B

ICD-9 Finland

Delivery in a completely normal case[PARTUS SINE COMPLICATIONE]

1.4

18.3

1049

5700

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

3.1

18.3

104

242

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

8.2

18.3

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.3

18.1

1564

9080

LCB20

NOMESCO Finland

Transvaginal myomectomy

36.4

18.0

ZX070

NOMESCO Finland

Intensity modified radiotherapy

152.6

18.0

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.8

17.9

319

1303

SPAT1153

SPAT

Removal of sutures

1.4

17.8

1118

6171

WX702

NOMESCO Finland

Supraglottic ventilation device

1.9

17.7

262

1001

8520/3-C50.9

ICD-O-3

Lobular carcinoma, NOS, of breast, NOS

+∞

17.4

8090/3-C44.3

ICD-O-3

Basal cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

17.4

Z30.1

ICD-10 Finland

Insertion of (intrauterine) contraceptive device

0.7

16.9

1026

9504

N93.8

ICD-10 Finland

Other specified abnormal uterine and vaginal bleeding

2.3

16.9

161

511

8500/3-C50.2

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-inner quadrant of breast

+∞

16.5

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

+∞

16.5

N920, D259

ICD-10 Finland

+∞

16.5

N921, D250

ICD-10 Finland

+∞

16.5

TPH07

NOMESCO Finland

Cathetrisation of artery

2.0

16.4

215

785

MA1AE

NOMESCO Finland

Ultrasound examination of early pregnancy (before 12. postmenstrual week)

0.7

16.2

772

7420

WB123

NOMESCO Finland

Demanding adjuvant cytostatic therapy

138.0

16.2

C50.91

ICD-10 Finland

Malignant tumor in another specified localization in ductal mammary gland

138.0

16.2

JAH01

NOMESCO Finland

Laparoscopy

1.7

16.2

378

1679

A04AA01

ATC

ondansetron; systemic, rectal

2.2

16.1

180

615

C64.88

ICD-10 Finland

Other malignant neoplasm of kidney, except renal pelvis

72.7

16.1

JN3AD

NOMESCO Finland

Abdominal CT examination

1.9

16.0

246

955

LBF01

NOMESCO Finland

Laparoscopic perfusion of Fallopian tube

2.0

16.0

222

829

A03FA01

ATC

metoclopramide; systemic, rectal

1.4

15.9

864

4640

TMA00

NOMESCO Finland

Episiotomy

0.5

15.7

154

2074

L02AE02

ATC

leuprorelin; implant, parenteral

2.2

15.7

175

598

C20.91

ICD-10 Finland

Malignant tumor of the rectum invasive carcinoma

+∞

15.6

JN5PN

NOMESCO Finland

Isotope imaging of secondary neoplasms of thyroid origin

+∞

15.6

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

+∞

15.6

L02AE03

ATC

goserelin; implant

3.4

15.5

171

JN4CD

NOMESCO Finland

Very extensive body CT

5.1

15.4

N97.8

ICD-10 Finland

Female infertility of other origin

1.9

15.4

243

953

ZXC96

NOMESCO Finland

Robot assisted procedure

5.0

15.3

HA1CG

NOMESCO Finland

Extensive MRI examination of mammary gland with high intensity magnet

4.4

15.2

C50.11

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,ductal tumor

69.0

15.2

LDB00

NOMESCO Finland

Excision of lesion of cervix uteri

2.7

15.1

104

277

WZC30

NOMESCO Finland

Teaching

1.6

14.9

383

1746

C81.1

ICD-10 Finland

Nodular sclerosis classical Hodgkin lymphoma

+∞

14.7

C73

ICD-10 Finland

Malignant neoplasm of thyroid gland

+∞

14.7

THW99

NOMESCO Finland

Other minor procedure in surgery of mammary gland

6.2

14.6

G03DC03

ATC

lynestrenol; oral

1.9

14.5

215

824

O99.80

ICD-10 Finland

The fear of childbirth

0.6

14.5

282

3199

MA2XE

NOMESCO Finland

Other obstetric ultrasound examination

0.7

14.5

534

5356

WX110

NOMESCO Finland

Local anesthesy

1.2

14.4

4186

27954

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.3

14.3

1296

7538

C56.00

ICD-10 Finland

Malignant tumor of the ovary without histology

+∞

13.7

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

+∞

13.7

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

43.6

13.5

N94.5

ICD-10 Finland

Secondary dysmenorrhoea

1.9

13.5

216

851

WX720

NOMESCO Finland

Own respiration

2.1

13.5

161

566

JAL21

NOMESCO Finland

Laparoscopic excision or destruction of lesion of peritoneum

2.0

13.5

174

634

ZZQ00

NOMESCO Finland

Free microvascular graft of skin

17.8

13.3

JAP00

NOMESCO Finland

Freeing of adhesions in the peritoneal cavity

3.9

13.1

105

LCC10

NOMESCO Finland

Supravaginal hysterectomy

8.8

13.0

Y83.6

ICD-10 Finland

Removal of other organ (partial) (total) as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

7.1

12.9

8500/3-C50.5

ICD-O-3

Infiltrating duct carcinoma, NOS, of lower-outer quadrant of breast

+∞

12.8

8380/3-C54.1

ICD-O-3

Endometrioid adenocarcinoma, NOS, of endometrium

+∞

12.8

LAE11

NOMESCO Finland

Unilateral laparoscopic oophorectomy

3.7

12.8

115

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.6

12.8

317

1432

UJF32

NOMESCO Finland

Coloscopy

1.4

12.7

803

4416

N80.9

ICD-10 Finland

Endometriosis, unspecified

1.8

12.7

240

1001

D39.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Female genital organ, unspecified

8.4

12.7

JAL20

NOMESCO Finland

Excision or destruction of lesion of peritoneum

5.0

12.7

I97.2

ICD-10 Finland

Postmastectomy lymphoedema syndrome

58.1

12.6

BAA40

NOMESCO Finland

Unilateral lobectomy of thyroid gland

2.3

12.5

116

366

MA2DE

NOMESCO Finland

Detailed ultrasound examination of fetus including color doppler method

0.7

12.4

630

6016

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.5

12.3

482

2424

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

1.7

12.3

252

1077

O80.8

ICD-10 Finland

Other single spontaneous delivery

0.6

12.2

220

2540

JN2DM

NOMESCO Finland

Lower part of abdomen very extensive MRI examination with Tesla magnet

8.9

12.2

N70.1

ICD-10 Finland

Chronic salpingitis and oophoritis

2.4

12.2

103

309

N73.6

ICD-10 Finland

Female pelvic peritoneal adhesions

2.5

12.1

100

298

YG1CD

NOMESCO Finland

Very extensive CT examination of thorax for dose design of radiotherapy

+∞

11.9

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

+∞

11.9

C50.82

ICD-10 Finland

Overall malignant tumor of the mammary gland, lobular tumor

+∞

11.9

R93.5

ICD-10 Finland

Abnormal findings on diagnostic imaging of other abdominal regions, including retroperitoneum

3.1

11.9

157

D64.9

ICD-10 Finland

Anaemia, unspecified

1.8

11.9

224

936

PJ3AT

NOMESCO Finland

Cytology of lymphnode with ultrasound guidance

6.2

11.8

XX7CT

NOMESCO Finland

Radioiodine therapy of thydoid tissue

5.3

11.8

O68.0

ICD-10 Finland

Labour and delivery complicated by fetal heart rate anomaly

0.7

11.8

326

3445

8302

FHL

Tumor removal (e.g., enucleation) or polyp removal

21.8

11.7

O24.4

ICD-10 Finland

Diabetes mellitus arising in pregnancy

0.7

11.6

681

6371

C09CA01

ATC

losartan; oral

1.4

11.6

523

2708

W14

ICPC

Contraception female other

0.6

11.5

187

2208

XMA22

NOMESCO Finland

General examination of pregnant woman

0.7

11.5

497

4864

A02BC05

ATC

esomeprazole; systemic

1.2

11.4

1910

11922

HAC15

NOMESCO Finland

Subcutaneous mastectomy with excision of mamilla

10.4

11.4

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.2

11.3

2207

13998

SPAT1193

SPAT

Pap smear

0.8

11.2

694

6452

G03DA02

ATC

medroxyprogesterone; systemic (pregnen (4) derivatives)

1.6

11.1

265

1186

WB402

NOMESCO Finland

Demanding antibody therapy of primary tumour

+∞

11.0

WF004

NOMESCO Finland

Palliative radiotherapy

+∞

11.0

8140/3-C20.9

ICD-O-3

Adenocarcinoma, NOS, of rectum, NOS

+∞

11.0

8500/3-C50.8

ICD-O-3

Infiltrating duct carcinoma, NOS, of overlapping lesion of breast

+∞

11.0

XX1XN

NOMESCO Finland

Other isotope examination

36.3

11.0

SPAT1200

SPAT

Guidance for breast-feeding and breast care

0.5

10.9

1253

O47.0

ICD-10 Finland

False labour before 37 completed weeks of gestation

0.8

10.8

694

6425

N84.1

ICD-10 Finland

Polyp of cervix uteri

2.0

10.8

149

557

SPAT1357

SPAT

Monitoring of problem during pregnancy

0.6

10.8

132

1670

N80.4

ICD-10 Finland

Endometriosis of rectovaginal septum and vagina

1.9

10.8

157

601

ZXD20

NOMESCO Finland

Day surgery

1.4

10.7

639

3477

ZXK00

NOMESCO Finland

Conversion from percutaneous endoscopic to open procedure

5.0

10.7

TQW99

NOMESCO Finland

Other minor procedure on skin

2.1

10.5

115

394

D41.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Kidney

5.4

10.5

N92.5

ICD-10 Finland

Other specified irregular menstruation

1.5

10.4

324

1551

R2110

NOMESCO Finland

Giving the first information

1.4

10.4

516

2723

C07AB07

ATC

bisoprolol; oral

1.3

10.3

1238

7435

WF002

NOMESCO Finland

Radical radiotherapy

7.3

10.2

Z51.0

ICD-10 Finland

Radiotherapy session

33.9

10.2

XLA10

NOMESCO Finland

1.5

10.1

383

1915

BAA60

NOMESCO Finland

Total thyroidectomy

2.1

10.1

121

430

8520/3-C50.4

ICD-O-3

Lobular carcinoma, NOS, of upper-outer quadrant of breast

+∞

10.1

C73.99

ICD-10 Finland

Malignant tumor of the thyroid gland (thyroid gland), other or unspecified histology

+∞

10.1

D50

ICD-10 Finland

Iron deficiency anaemia

1.9

10.1

145

553

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

47.1

10.0

C43.72

ICD-10 Finland

Malignant melanoma of the lower extremity including the hip: 'superficial spreading' type

87.1

9.9

Z51.5

ICD-10 Finland

Palliative care

5.2

9.9

SPAT1192

SPAT

Gynaecological examination

0.8

9.9

666

6128

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.4

9.9

251

8113

FHL

Fractional scraping

3.0

9.9

142

W85

ICPC

Gestational diabetes

0.6

9.8

180

2066

O48

ICD-10 Finland

Prolonged pregnancy

0.6

9.8

178

2047

HAB99

NOMESCO Finland

Other partial excision of mammary gland

2.7

9.8

177

M03BX02

ATC

tizanidine; oral

1.2

9.7

3931

26525

N95.0

ICD-10 Finland

Postmenopausal bleeding

1.9

9.7

148

577

SPAT1317

SPAT

Planned health check-up monitoring, health check-up performed based on individual need

0.7

9.6

518

4910

Y60.0

ICD-10 Finland

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care during surgical operation

5.0

9.6

N25.9

ICD-10 Finland

Disorder resulting from impaired renal tubular function, unspecified

25.4

9.6

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

25.4

9.6

YX9BD

NOMESCO Finland

Other extensive CT eamination for dose design of radiotherapy

25.4

9.6

Z2221

NOMESCO Finland

Medical doctor

1.2

9.5

1662

10380

Z36.0

ICD-10 Finland

Antenatal screening for chromosomal anomalies

0.7

9.5

282

2939

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

1.8

9.4

157

633

LAC21

NOMESCO Finland

Laparoscopic destruction of lesion of ovary

2.0

9.4

117

422

WX400

NOMESCO Finland

Inhalation anesthesy

1.6

9.2

264

1239

N97.9

ICD-10 Finland

Female infertility, unspecified

1.3

9.2

691

3899

ZXE30

NOMESCO Finland

More than five and less than seven hours

2.0

9.2

118

433

C54.22

ICD-10 Finland

Endometrial stromal cell sarcoma

+∞

9.2

FM1FN

NOMESCO Finland

Heart function isotope examination

+∞

9.2

C56.71

ICD-10 Finland

Serous epithelial malignant tumor of the ovary

+∞

9.2

8720/3-C44.9

ICD-O-3

Malignant melanoma, NOS, of skin, NOS

+∞

9.2

C56.73

ICD-10 Finland

Endomeroid epithelial carcinoma of the ovary

+∞

9.2

C73.90

ICD-10 Finland

Malignant tumor of the thyroid gland (thyroid gland) without histology

+∞

9.2

LAF16

NOMESCO Finland

Excision of uterus, adnexes and lymph nodes for treatment of ovarian cancer

43.5

9.1

N02AJ06

ATC

codeine and paracetamol; systemic

1.2

9.1

1847

11697

C09DA01

ATC

losartan and diuretics; oral

1.7

9.1

183

782

N85.0

ICD-10 Finland

Endometrial glandular hyperplasia

2.2

9.1

293

Z32.1

ICD-10 Finland

Pregnancy confirmed

0.8

9.1

764

6844

W84

ICPC

Pregnancy high risk

0.6

9.0

150

1759

WX002

NOMESCO Finland

Sedation and analgesia

1.3

9.0

598

3309

H01CA02

ATC

nafarelin; nasal

1.5

8.9

325

1613

HAE99

NOMESCO Finland

Other reconstruction of breast

6.2

8.9

N99.4

ICD-10 Finland

Postprocedural pelvic peritoneal adhesions

2.6

8.8

175

XX1XW

NOMESCO Finland

Extensive written report from radiologist

2.4

8.8

229

ZZQ10

NOMESCO Finland

Free microvascular graft of skin and muscle

23.6

8.7

G03DA04

ATC

progesterone; systemic, rectal, vaginal

1.5

8.7

275

1324

L02BG04

ATC

letrozole; oral

1.7

8.6

188

824

LAA10

NOMESCO Finland

Percutaneous or transvaginal puncture and recovery of oocyte

1.5

8.6

263

1259

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

1.8

8.5

149

610

ZZR10

NOMESCO Finland

Flap of skin and muscle

13.6

8.5

ZXA00

NOMESCO Finland

Right side

1.3

8.4

753

4349

C18.71

ICD-10 Finland

Malignant tumor of the sigmoid invasive carcinoma

+∞

8.2

C18.70

ICD-10 Finland

Malignant tumor of the sigmoid without histology

+∞

8.2

WB223

NOMESCO Finland

Demanding adjuvant hormone therapy of malignancy

+∞

8.2

C78.6

ICD-10 Finland

Secondary malignant neoplasm of retroperitoneum and peritoneum

+∞

8.2

N920, D250

ICD-10 Finland

+∞

8.2

C20.90

ICD-10 Finland

Malignant tumor of the rectum without histology

+∞

8.2

C73.92

ICD-10 Finland

Follicular carcinoma of the thyroid gland

+∞

8.2

8090/3-C44.5

ICD-O-3

Basal cell carcinoma, NOS, of skin of trunk

+∞

8.2

C54.21

ICD-10 Finland

Leiomyosarcoma and myometrium

+∞

8.2

C50.4

ICD-10 Finland

Malignant neoplasm: Upper-outer quadrant of breast

+∞

8.2

C43.52

ICD-10 Finland

Malignant melanoma on the torso: 'superficial spreading' type

+∞

8.2

D50.8

ICD-10 Finland

Other iron deficiency anaemias

2.3

8.2

247

R4110

NOMESCO Finland

Physiotherapy

1.3

8.2

909

5393

SPAT1399

SPAT

Acceptance of acknowledgement of paternity of child born outside of marriage before the birth of the child at the maternity clinic. Paternity Act, Section 16.

0.6

8.2

127

1514

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

1.3

8.2

674

3850

BA3AT

NOMESCO Finland

Cytology of thyroid with ultrasound quidance

2.7

8.2

152

SPAT1189

SPAT

Other ultrasound examination during pregnancy

0.6

8.2

124

1485

ZXA05

NOMESCO Finland

Left side

1.3

8.2

689

3951

KCH01

NOMESCO Finland

Percutaneous endoscopic suture of bladder

14.5

8.1

N92

ICD-10 Finland

Excessive, frequent and irregular menstruation

1.7

8.1

151

634

JAL30

NOMESCO Finland

Omentectomy

5.2

8.1

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.2

8.0

1011

6090

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

1.7

7.9

148

621

M01AB05

ATC

diclofenac; systemic, rectal

1.2

7.9

3798

25760

LEE00

NOMESCO Finland

Suture of vagina

5.9

7.9

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.8

7.9

122

482

A02BC03

ATC

lansoprazole; oral

1.2

7.9

1172

7188

R18

ICD-10 Finland

Ascites

4.4

7.8

O63.1

ICD-10 Finland

Prolonged second stage (of labour)

0.6

7.8

173

1908

ZZF00

NOMESCO Finland

Graft of adipose tissue

4.1

7.8

C10AA07

ATC

rosuvastatin; oral

1.4

7.8

364

1901

D39.19

ICD-10 Finland

Tumor of uncertain or unknown nature in the ovary with unspecified histology

4.0

7.8

M01AH05

ATC

etoricoxib; oral

1.2

7.7

3229

21647

KBV12

NOMESCO Finland

Transluminal endoscopic removal of stent from ureter

2.7

7.7

139

JAH00

NOMESCO Finland

Laparotomy

2.3

7.7

235

PJD54

NOMESCO Finland

Block dissection of iliac lymph nodes

26.6

7.7

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.5

7.6

263

1293

WW500

NOMESCO Finland

Blood transfusion

1.9

7.6

110

425

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.4

7.6

413

2218

O70.1

ICD-10 Finland

Second degree perineal laceration during delivery

0.6

7.5

113

1354

N83.1

ICD-10 Finland

Corpus luteum cyst

1.8

7.5

135

561

PJ2AT

NOMESCO Finland

Biopsy of lymphnode with ultrasound guidance

7.3

7.5

UKC02

NOMESCO Finland

Cystoscopy

1.4

7.5

304

1549

N02AA05

ATC

oxycodone; systemic

1.5

7.5

238

1152

QB2S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in chest

5.6

7.3

9707

FHL

Ablation of mammae and removal of axillary lymph nodes

+∞

7.3

8720/3-C44.5

ICD-O-3

Malignant melanoma, NOS, of skin of trunk

+∞

7.3

8091/3-C44.9

ICD-O-3

Superficial basal cell carcinoma of skin, NOS

+∞

7.3

4CJ01

NOMESCO Finland

+∞

7.3

N921, D259

ICD-10 Finland

+∞

7.3

WB133

NOMESCO Finland

Very demanding adjuvant cytostatic therapy

+∞

7.3

C43.62

ICD-10 Finland

Malignant melanoma of upper extremity including shoulder: 'superficial spreading' type

+∞

7.3

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

+∞

7.3

C50.22

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,lobular tumor

+∞

7.3

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

+∞

7.3

Z85.3

ICD-10 Finland

Personal history of malignant neoplasm of breast

65.3

7.3

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.4

7.2

323

1673

TPX10

NOMESCO Finland

Implantation of vascular injection port

2.5

7.2

169

XLD10

NOMESCO Finland

Gynaecological examination

2.9

7.1

106

N97.2

ICD-10 Finland

Female infertility of uterine origin

4.6

7.0

ZXE00

NOMESCO Finland

One hour or less

1.2

7.0

2200

14390

G03GA01

ATC

chorionic gonadotrophin; parenteral

1.3

7.0

495

2769

SPAT1195

SPAT

Antenatal classes

0.6

7.0

109

1296

ZZR00

NOMESCO Finland

Flap of skin

4.3

6.9

M01AE02

ATC

naproxen; oral, rectal

1.2

6.9

3344

22583

HAD99

NOMESCO Finland

Other plastic operation on breast

4.1

6.9

ZX013

NOMESCO Finland

Radiotherapy with large shaped fields - SSD therapy

24.2

6.9

Z30.0

ICD-10 Finland

General counselling and advice on contraception

0.8

6.8

386

3636

N05CF02

ATC

zolpidem; oral

1.2

6.7

903

5471

G03GA06

ATC

follitropin beta; parenteral

1.4

6.7

336

1777

J01MA12

ATC

levofloxacin; systemic

1.3

6.7

544

3104

QCE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in upper limb

2.2

6.6

211

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.4

6.6

349

1864

YL1BD

NOMESCO Finland

Extensive CT examination of pelvis for dose design of radiotherapy

32.6

6.6

HA6HA

NOMESCO Finland

Tomosynthesis assessment of mammary gland specimen

32.6

6.6

D27.91

ICD-10 Finland

Benign epithelial tumor of the ovary (ovary)

2.3

6.5

171

JAL01

NOMESCO Finland

Laparoscopic biopsy of peritoneum

4.8

6.4

PJD64

NOMESCO Finland

Laparoscopic dissection of iliac lymph nodes

58.1

6.4

C44.41

ICD-10 Finland

Basocellular carcinoma of the skin of the scalp and neck

58.1

6.4

C50.29

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland, other or undeterminated histology

+∞

6.4

C79.30

ICD-10 Finland

Secondary malignant tumor of the cerebrum

+∞

6.4

8500/3-C50.3

ICD-O-3

Infiltrating duct carcinoma, NOS, of lower-inner quadrant of breast

+∞

6.4

C50.20

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,no histological veryfication

+∞

6.4

PJ5AQ

NOMESCO Finland

Sentinell lymphnode SPECT with low dose CT

+∞

6.4

C50.19

ICD-10 Finland

Malignant tumor of the central part of the mammary gland, other or undeterminated histology

+∞

6.4

1501

Kela drug reimbursment

Palbociclib

+∞

6.4

C77.3

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Axillary and upper limb lymph nodes

+∞

6.4

JN5AQ

NOMESCO Finland

SPECT of thyroid metastasis with low-dose CT

+∞

6.4

D37.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts

2.8

6.4

108

N80.5

ICD-10 Finland

Endometriosis of intestine

2.1

6.4

238

Z30.8

ICD-10 Finland

Other contraceptive management

0.6

6.4

1001

Z08.7

ICD-10 Finland

Follow-up examination after combined treatment for malignant neoplasm

18.1

6.4

KBV02

NOMESCO Finland

Cystoscopic insertion of stent into ureter

2.1

6.4

249

LAC00

NOMESCO Finland

Excision of ovarian cyst

3.0

6.3

M01AE03

ATC

ketoprofen; systemic, rectal

1.2

6.3

1722

11131

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

1.9

6.2

333

LGA21

NOMESCO Finland

Laparoscopic sterilisation by constriction of Fallopian tubes

1.3

6.2

376

2054

D26.1

ICD-10 Finland

Other benign neoplasm: Corpus uteri

5.9

6.2

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

5.9

6.2

N94.6

ICD-10 Finland

Dysmenorrhoea, unspecified

1.6

6.2

159

732

E04.2

ICD-10 Finland

Nontoxic multinodular goitre

1.6

6.1

139

619

ZX120

NOMESCO Finland

Intravenous

1.4

6.1

260

1336

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.6

6.1

164

763

SPAT1273

SPAT

Structured assessment of psychoactive substance / tobacco use

0.6

6.1

116

1316

Z71.8

ICD-10 Finland

Other specified counselling

1.2

6.1

1317

8347

PJA01

NOMESCO Finland

Laparoscopic sentinel node excision

21.8

6.1

LBF00

NOMESCO Finland

Perfusion of Fallopian tube

2.2

6.0

186

HA1CM

NOMESCO Finland

Mammary gland extensive MRI examination with 3 Tesla magnet

5.2

6.0

Y69

ICD-10 Finland

Unspecified misadventure during surgical and medical care

2.6

6.0

116

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3044640) Blood type and Crossmatch panel - Blood

8172

29483

1.83

307.65

2.1

1.9

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

2513

5102

2.97

307.65

3.3

1.6

ug/l

20.7

9.2

1.12

1890

3655

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

680

251

15.66

307.65

3.5

1.2

u/ml

37.1

26.5

0.54

654

227

(3002256) Pathology report gross observation

3958

10431

2.35

307.65

1.3

1.1

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

3106

6854

2.77

307.65

2.7

1.5

u/ml

40.5

25.5

5.32

3006

6564

(4035726)

2320

3375

4.16

307.65

1.4

1.2

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

11773

46623

1.79

307.65

3.7

3.5

—

(40768804) Tissue Pathology biopsy report

12108

44827

2.00

307.65

2.2

1.7

—

(1617658) Protocol used for examination of sentinel lymph nodes

284

47.58

298.18

1.0

—

(40768793) Breast Pathology biopsy report

973

1334

4.23

292.58

1.3

1.2

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

6125

21776

1.77

270.10

2.1

1.9

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

1516

3220

2.76

238.38

1.5

1.4

pmol/l

102.5

66.9

2.78

1483

3146

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

11905

51674

1.56

233.14

5.6

3.5

umol/l

10.0

10.1

0.73

11233

48163

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

282

132

12.16

198.70

6.2

1.4

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

17617

85337

1.54

189.72

7.2

5.3

u/l

76.2

74.1

10.54

16506

79739

(4281824)

549

734

4.28

169.50

1.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

188

15.46

147.77

1.1

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

8121

35091

1.45

137.99

3.2

2.0

mmol/l

2.4

9.15

7043

30367

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

10163

45801

1.42

137.10

5.4

4.5

mmol/l

1.2

4.59

9136

41129

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

11242

51683

1.41

134.59

6.1

5.0

mmol/l

1.2

2.09

9426

43803

(3032080) INR in Blood by Coagulation assay

8273

36193

1.43

129.37

7.0

6.7

inr

1.1

1.2

1.04

2467

10823

(3019550) Sodium [Moles/volume] in Serum or Plasma

22917

120923

1.74

129.27

13.9

11.3

mmol/l

139.8

0.11

22445

117733

(3023103) Potassium [Moles/volume] in Serum or Plasma

22976

121345

1.75

128.67

14.1

11.4

mmol/l

3.9

8.05

22472

117912

(3024561) Albumin [Mass/volume] in Serum or Plasma

9590

43382

1.40

121.96

4.1

3.6

g/l

36.2

36.4

4.31

8830

39852

(3013650) Neutrophils [#/volume] in Blood by Automated count

13095

62510

1.37

119.29

8.5

6.7

e9/l

4.0

2.71

11382

54566

(3031040) Bacteria [#/volume] in Urine by Automated count

15409

75794

1.37

114.01

4.6

4.2

e6/l

1438.7

2120.0

1.00

161

875

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

804

1847

2.50

107.46

1.2

—

(40768795) Lymph node Pathology biopsy report

253

250

5.75

107.00

1.1

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

12514

60079

1.34

103.13

4.0

3.7

mmol/l

6.5

0.14

11740

55306

(3023368) Bacteria identified in Blood by Culture

5063

21091

1.44

97.77

3.8

3.5

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

21275

111584

1.47

97.65

11.8

9.0

ml/min/173m2

82.8

83.7

8.48

17754

90117

(3013512) EKG study

6589

28864

1.39

95.32

3.6

3.3

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

182

141

7.32

94.21

1.2

1.1

—

(3033658) Prothrombin time (PT) actual/Normal

5754

24883

1.39

88.67

3.4

3.2

98.2

96.6

5.28

5586

24036

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

22407

119479

1.51

82.77

13.0

10.4

mg/l

20.4

18.8

9.86

17818

90794

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

2059

7290

1.64

82.34

2.2

2.1

g/l

0.2

4.12

1940

6703

(3020564) Creatinine [Moles/volume] in Serum or Plasma

23540

127175

1.64

77.56

14.7

11.3

umol/l

68.4

68.5

0.25

23531

127101

(3012095) Magnesium [Moles/volume] in Serum or Plasma

3485

14131

1.45

75.28

2.9

2.4

mmol/l

0.8

6.29

3226

12949

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

2117

7794

1.58

71.81

4.0

2.7

u/l

238.3

234.8

0.58

1980

7254

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

7629

35419

1.31

70.14

3.1

3.0

—

0.1

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

751

2031

2.12

69.31

2.8

2.1

u/ml

279.2

122.0

0.83

625

1638

(3037467) Urinalysis macro (dipstick) panel - Urine

15746

80265

1.28

68.35

4.5

4.2

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

2327

8893

1.52

66.67

2.9

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

360

697

2.94

66.02

5.4

1.1

u/ml

82.8

203.4

1.83

115

166

(3018418) pH of Serum or Plasma

6721

30900

1.31

65.32

4.0

3.1

7.4

0.64

1266

5236

(3044889) 12 lead EKG panel

15556

79797

1.26

58.95

3.4

3.2

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

23543

128016

1.54

58.74

10.4

8.3

u/l

24.8

23.8

8.71

22758

123816

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

447

1047

2.43

57.39

2.9

2.0

u/ml

1268.7

344.6

0.69

397

938

(3019225) pH of Specimen

2441

9702

1.46

57.32

3.9

3.3

—

(40758558) Short blood count panel - Blood

5772

26408

1.30

56.55

6.2

4.9

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

140

147

5.39

56.12

2.3

1.2

ng/l

76.9

59.0

0.52

(42870588) Differential panel, method unspecified - Blood

7648

36350

1.27

55.13

5.6

—

(40761511) CBC panel - Blood by Automated count

23260

126396

1.47

53.74

12.5

10.0

—

(3013707) Erythrocyte sedimentation rate by Westergren method

17531

91621

1.26

52.98

4.2

4.0

mm/h

11.4

11.3

0.57

16296

85982

(3030467) Casts [#/volume] in Urine by Automated count

5850

27036

1.29

52.33

2.9

2.8

e6/l

0.3

0.4

0.29

4327

19926

(3002582) Erythrocytes [#/volume] in Urine

6326

29542

1.28

52.02

3.0

2.8

e6/l

103.4

53.3

1.25

4762

22038

(3018095) Leukocytes [#/volume] in Urine

7679

36793

1.25

50.56

3.5

3.3

e6/l

95.4

94.8

0.02

5282

24522

(36304419) Bacteria [Presence] in Urine

5778

26798

1.28

49.81

2.9

2.7

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

7286

34897

1.25

47.38

2.4

2.2

u/l

56.4

57.8

0.76

6680

32122

(3042936) Bacteria identified in Isolate by Culture

2926

12435

1.37

46.45

1.9

—

(3002030) Lymphocytes/100 leukocytes in Blood

10963

54935

1.22

46.13

5.7

29.1

29.7

7.56

10135

51233

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

553

5741

0.53

45.02

1.4

1.5

—

(3019069) Monocytes/100 leukocytes in Blood

10644

53288

1.22

44.65

6.0

5.9

8.1

0.15

9900

49988

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

5507

25703

1.26

44.15

2.7

ng/l

985.5

1042.7

0.44

4552

21476

(3006504) Eosinophils/100 leukocytes in Blood

10592

53061

1.21

43.86

5.7

2.8

2.9

1.73

9788

49399

(3026008) Bacteria identified in Urine by Culture

7362

35629

1.23

42.38

3.1

2.9

—

(3026782) Osmolality of Urine

4138

18721

1.29

42.31

2.7

2.5

mosm/kgh2o

512.0

510.0

0.18

3516

15694

(3018010) Neutrophils/100 leukocytes in Blood

10796

54312

1.21

42.20

5.5

5.6

56.8

56.3

3.83

10027

50865

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

2004

8126

1.42

41.67

3.4

3.3

ng/l

83.0

79.7

0.93

1704

7006

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

7996

39167

1.22

40.48

3.2

3.0

ng/l

29.1

54.0

1.72

4663

21350

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

21680

117252

1.30

40.12

4.5

4.2

mmol/l

5.8

5.7

8.40

19884

109350

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

3044

13293

1.33

40.01

4.5

4.2

32.7

32.9

0.41

2108

9495

(3007461) Platelets [#/volume] in Blood

24424

134828

1.65

39.60

19.8

15.6

e9/l

270.0

266.7

12.36

23935

131545

(3022096) Basophils/100 leukocytes in Blood

10214

51315

1.20

39.55

5.8

5.7

0.7

0.70

9433

47784

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

4167

19015

1.28

39.54

2.6

2.1

mmol/l

2.5

2.4

14.73

3658

16277

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

20409

109657

1.25

38.76

5.5

5.0

mmol/mol

38.9

38.7

4.09

18841

102978

(3010813) Leukocytes [#/volume] in Blood

24439

134980

1.65

38.48

19.8

15.6

e9/l

6.6

6.5

1.20

23891

131348

(3024731) MCV [Entitic volume]

24434

134948

1.65

38.42

19.7

15.5

90.5

90.8

21.45

24167

133216

(3026361) Erythrocytes [#/volume] in Blood

24435

134960

1.64

38.30

19.8

15.6

e12/l

4.5

4.4

0.16

23888

131365

(3035941) MCH [Entitic mass]

24431

134935

1.64

38.24

19.7

15.5

30.0

30.1

37.31

24165

133209

(3000963) Hemoglobin [Mass/volume] in Blood

24439

135000

1.64

38.01

19.9

15.6

g/l

132.7

133.6

25.63

24181

133282

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

3332

14855

1.30

37.59

2.6

2.5

e6/l

4.8

5.2

0.55

1722

7662

(3022145) Colonoscopy Study observation

2808

12288

1.32

36.11

1.3

—

(3019832) Treponema pallidum Ab [Presence] in Serum

1379

10984

0.69

35.95

1.5

1.6

—

(3021601) Nitrite [Presence] in Urine by Test strip

11493

58695

1.19

35.76

5.1

4.8

estimate

0.0

4.20

2179

10283

(3050129) First trimester maternal screen panel - Serum or Plasma

346

3868

0.50

35.64

1.4

—

(3009261) Glucose [Presence] in Urine by Test strip

11589

59250

1.19

35.51

3.8

3.6

estimate

0.0

0.02

2175

10228

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

21644

117363

1.27

35.31

5.6

5.1

mu/l

2.1

2.0

0.30

20053

110286

(3013115) Eosinophils [#/volume] in Blood

11665

59715

1.19

35.03

5.7

e9/l

0.2

1.41

10283

53372

(3019198) Lymphocytes [#/volume] in Blood

11548

59130

1.18

34.28

5.5

5.6

e9/l

1.9

0.76

10217

52941

(3000850) Epithelial cells [#/volume] in Urine

4414

20644

1.25

33.37

2.5

2.4

e6/l

7.3

7.6

0.59

3801

17866

(3001604) Monocytes [#/volume] in Blood

11216

57368

1.18

33.35

5.5

5.6

e9/l

0.5

0.05

9707

50467

(3021589) Normoblasts [#/volume] in Blood

9924

50255

1.19

33.07

9.1

7.6

e9/l

0.0

1.00

8099

41276

(3006315) Basophils [#/volume] in Blood

11253

57614

1.18

32.89

5.5

5.6

e9/l

0.0

0.19

9718

50627

(3022948) Iron [Moles/volume] in Serum or Plasma

3463

15774

1.27

32.69

2.3

umol/l

13.3

13.7

2.94

3186

14507

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

161

301

3.03

31.56

1.7

1.4

ug/l

18.9

30.5

0.64

156

293

(3003694) ABO and Rh group [Type] in Blood

5765

27892

1.21

31.25

1.4

1.5

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

19274

103534

1.21

31.13

4.7

4.4

pmol/l

14.7

14.5

14.86

17751

96652

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

10475

53476

1.18

30.99

2.3

nmol/l

8771.2

77.9

0.50

9433

48907

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

5630

27215

1.21

30.69

2.3

2.2

mg/l

3.1

2.8

9.89

4767

23484

(3026493) Urate [Moles/volume] in Serum or Plasma

5760

27933

1.21

30.31

2.2

2.0

umol/l

3288.0

3712.2

0.41

4932

24401

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

2861

12837

1.29

30.25

2.4

22.0

23.0

3.13

2449

10904

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

7554

37578

1.19

30.07

3.1

2.7

u/l

30.5

29.9

0.42

7172

35655

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

267

668

2.26

29.91

1.1

1.3

—

(40761536) Microorganisms panel - Urine sediment

2114

9116

1.33

29.79

4.2

3.6

—

(3027945) Reticulocytes/100 erythrocytes in Blood

2069

8927

1.33

29.01

2.4

2.2

1.8

0.18

1812

7805

(3018677) aPTT in Platelet poor plasma by Coagulation assay

2930

13264

1.28

28.78

2.0

1.9

29.4

29.3

0.27

2840

12788

(3035350) Ketones [Presence] in Urine by Test strip

11340

58501

1.17

28.54

3.8

3.6

estimate

0.0

0.23

2164

10077

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

3576

16625

1.25

27.97

2.5

2.4

e6/l

1.3

0.02

1968

9343

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

3066

14006

1.27

27.90

1.8

1.7

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

253

2885

0.49

27.70

1.3

1.5

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

2634

11819

1.29

27.69

2.3

2.1

umol/l

6.0

5.9

0.17

2227

9861

(3004789) Transferrin [Mass/volume] in Serum or Plasma

3102

14210

1.26

27.55

2.3

g/l

2.5

2.4

0.42

2841

13047

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

318

3355

0.53

27.27

1.3

1.4

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

260

672

2.19

27.05

3.7

1.5

nmol/l

5.0

3.4

0.88

251

635

(3023520) Reticulocytes [#/volume] in Blood

1520

6323

1.38

26.92

2.5

2.2

e9/l

71.5

0.02

1120

4685

(3003458) Phosphate [Moles/volume] in Serum or Plasma

2543

11407

1.28

26.75

5.0

4.5

mmol/l

1.0

0.80

2343

10519

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

298

3184

0.52

26.64

1.3

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

298

3182

0.52

26.59

1.3

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

297

3171

0.52

26.49

1.3

1.4

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1117

4414

1.45

26.47

6.0

6.4

mmol/l

25.0

24.9

0.19

1109

4368

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1856

7989

1.33

26.37

3.5

2.7

mmol/l

1.2

0.82

1605

6786

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

297

3160

0.52

26.20

1.3

1.4

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

15423

81780

1.16

25.72

3.0

2.8

u/l

41.6

36.9

8.63

14422

77191

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

5521

27044

1.19

25.27

1.7

mg/l

1.0

0.9

1.12

4153

20423

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

689

2503

1.57

24.39

2.1

2.6

g/l

3.5

3.6

1.32

649

2347

(3047352) Trisomy 18 risk [Likelihood] in Fetus

246

2671

0.51

23.21

1.3

1.4

—

(3005033) Fetal Nuchal fold Thickness US

245

2663

0.51

23.19

1.3

1.4

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

257

2748

0.52

23.08

1.4

1.5

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

5214

33457

0.85

22.71

1.4

1.5

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

529

1848

1.63

22.05

2.9

3.5

u/ml

0.4

0.06

309

1077

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

8974

46076

1.15

21.97

1.9

pmol/l

101.6

99.9

2.12

4269

22612

(3049717) Cytology report of Urine Cyto stain

574

2048

1.59

21.96

2.2

1.8

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

22452

123288

1.24

21.95

4.9

4.5

mmol/l

3.0

2.9

4.38

20698

115811

(3020682) Albumin/Creatinine [Ratio] in Urine

6070

30277

1.17

21.84

3.8

mg/mmol

8.7

7.2

1.11

3472

17603

(3042111) Morphology [Interpretation] in Bone marrow Narrative

298

885

1.91

21.59

1.7

1.2

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

572

2053

1.58

21.37

1.3

nmol/l

0.4

0.5

0.18

427

1641

(3014576) Chloride [Moles/volume] in Serum or Plasma

2211

10011

1.27

21.35

6.3

6.0

mmol/l

104.5

104.3

1.29

2180

9780

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

6552

32948

1.16

21.09

2.0

u/l

148.7

158.8

0.59

6126

30882

(3045142) Bone marrow Pathology biopsy report

208

545

2.16

21.07

1.3

1.1

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

2123

9620

1.27

20.34

2.3

2.2

u/l

38.2

36.4

0.26

1835

8125

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

22140

121577

1.21

19.84

4.4

4.1

mmol/l

5.0

4.9

9.02

20518

114737

(40768797) Stomach Pathology biopsy report

3510

16830

1.20

19.71

1.2

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

21275

116420

1.19

19.62

3.9

3.7

mmol/l

1.3

1.2

50.67

19454

109039

(3012516) Albumin [Mass/volume] in Urine

5762

28831

1.16

19.52

3.1

mg/l

463.6

412.2

0.28

3236

16436

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1541

6738

1.31

19.49

1.6

1.5

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

233

2428

0.54

19.27

1.7

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

22000

120826

1.20

18.82

4.4

4.1

mmol/l

1.6

3.27

20295

113763

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

438

1525

1.63

18.58

1.4

1.2

ug/l

4.9

2.8

0.90

331

1354

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

6293

31791

1.15

18.57

1.7

1.6

mmol/l

1.4

1.3

11.55

5248

27316

(3014111) Lactate [Moles/volume] in Serum or Plasma

1534

6752

1.30

18.46

6.3

mmol/l

1.2

1.3

2.24

1483

6510

(3041096) Erythrocytes [Presence] in Urine by Automated

6383

32321

1.15

18.15

3.4

3.1

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

11020

57924

1.13

17.42

3.0

2.8

ug/l

91.4

80.4

6.13

10244

54460

(3003396) Base excess in Arterial blood by calculation

1913

8724

1.25

17.29

6.6

6.5

mmol/l

1.0

1.3

3.53

1532

6732

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1914

8732

1.25

17.24

6.6

6.5

kpa

5.1

0.87

1821

8310

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

4.33

17.22

1.6

1.1

ug/l

3.3

2.5

0.28

(3027801) Oxygen [Partial pressure] in Arterial blood

1912

8731

1.25

17.08

6.6

6.5

kpa

13.0

12.2

7.51

1815

8303

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1583

7081

1.28

16.80

7.2

7.3

g/l

119.8

121.0

1.59

1518

6801

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

587

2238

1.49

16.79

1.6

—

(3000991) Gas panel - Venous blood

1414

6240

1.29

16.68

7.9

7.6

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1100

4692

1.34

16.57

1.6

—

(3002385) Erythrocyte distribution width [Ratio]

18594

101057

1.14

16.38

15.6

12.4

13.7

13.6

15.39

18252

98786

(40768443) Skin Pathology biopsy report

1110

4779

1.32

15.69

1.2

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

326

1102

1.68

15.57

1.6

1.4

—

(3007853) Bacteria identified in Skin by Aerobe culture

2550

12118

1.21

15.51

1.7

—

(3020779) Urea [Moles/volume] in Serum or Plasma

1404

6254

1.28

15.40

7.0

6.6

mmol/l

8.6

8.9

0.68

1326

5947

(3021960) Folate [Moles/volume] in Serum or Plasma

4865

24425

1.15

15.15

1.5

nmol/l

21.4

21.5

0.15

4088

21138

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

8817

45996

1.12

15.08

3.9

3.7

—

(3009508) Creatinine [Moles/volume] in Urine

6144

31351

1.14

15.06

3.0

mmol/l

6.8

0.25

5074

26758

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

710

2868

1.41

15.02

2.1

2.4

180.4

171.2

1.89

666

2678

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

179

509

1.99

14.85

1.7

1.6

mg/l

2.9

3.0

0.24

166

487

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

2023

9441

1.23

14.75

3.5

3.1

pmol/l

4.5

0.10

1823

8373

(3020630) Protein [Mass/volume] in Serum or Plasma

1506

6809

1.26

14.63

2.6

1.5

g/l

66.7

67.1

1.25

1331

6115

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

277

914

1.72

14.48

1.9

u/ml

6.8

316.9

0.89

266

859

(3009343) pH of Capillary blood

1123

4900

1.30

14.44

3.1

3.0

7.4

0.16

166

601

(3016502) Oxygen saturation in Arterial blood

1664

7633

1.24

14.25

6.9

96.2

95.6

3.30

1596

7327

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

1082

4709

1.31

14.18

3.0

mmol/l

2.1

1.8

1.14

811

3449

(3004809) Band form neutrophils/100 leukocytes in Blood

312

1074

1.64

13.97

3.1

2.6

1.1

0.26

259

811

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

1132

4972

1.30

13.86

3.1

3.0

kpa

5.2

0.18

1039

4572

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

2024

9506

1.22

13.85

1.7

1.6

—

(3014007) Fractional oxyhemoglobin in Arterial blood

1042

4551

1.30

13.32

8.4

8.6

94.3

93.5

3.30

1037

4535

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

446

1693

1.49

13.14

1.6

1.4

—

(40768441) Liver Pathology biopsy report

200

617

1.83

13.13

1.3

1.4

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

191

1881

0.57

13.09

1.3

1.4

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

1035

4528

1.30

13.07

8.4

8.6

0.7

0.06

1029

4504

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

346

1245

1.57

12.99

2.0

mg/l

24.1

24.4

0.03

318

(3016879) Cocaine [Presence] in Urine

475

3819

0.69

12.95

1.3

2.0

—

(3027944) Amphetamines [Presence] in Urine

526

4150

0.71

12.86

1.3

1.9

—

(3000764) Benzodiazepines [Presence] in Urine

532

4189

0.71

12.85

1.3

2.0

—

(40768806) Pleura Pathology biopsy report

130

347

2.12

12.80

1.5

1.4

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

1162

0.46

12.76

1.1

1.2

—

(3028300) Cannabinoids [Presence] in Urine

538

4220

0.71

12.70

1.3

2.0

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

726

3030

1.36

12.69

1.9

2.1

96.1

97.1

0.48

659

2738

(3005719) IgG [Mass/volume] in Serum or Plasma

1767

8260

1.22

12.66

2.7

2.3

g/l

10.2

10.5

2.97

1584

7565

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

862

3694

1.33

12.64

1.9

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

904

3905

1.32

12.54

8.8

8.7

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

425

1619

1.49

12.34

1.6

1.4

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

+∞

12.33

1.0

0.0

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

923

0.41

12.23

1.3

1.5

mmol/l

8.6

7.8

1.12

579

(3027008) Opiates [Presence] in Urine

540

4206

0.72

12.23

1.3

1.9

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

2021

9607

1.20

12.18

1.7

1.6

—

(3019309) Folate [Moles/volume] in Red Blood Cells

3873

19404

1.15

12.13

1.7

nmol/l

1180.0

1197.9

0.55

2859

14990

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

624

2563

1.38

12.06

2.0

1.8

ug/l

1.4

2.1

1.50

527

2214

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

873

3782

1.31

11.88

8.3

8.7

mmol/l

24.4

24.5

0.45

817

3488

(3009542) Hematocrit [Volume Fraction] of Blood

20348

111820

1.13

11.86

14.0

11.5

39.2

39.4

4.18

15213

85638

(3025468) Yersinia sp identified in Specimen by Organism specific culture

343

1265

1.53

11.62

1.5

1.3

—

(3022217) INR in Platelet poor plasma by Coagulation assay

2380

11527

1.18

11.60

21.0

19.3

inr

1.2

0.26

365

1720

(3028026) IgM [Mass/volume] in Serum or Plasma

1379

6340

1.24

11.58

1.8

1.6

g/l

1.3

0.62

1251

5800

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

1029

4573

1.28

11.55

8.3

8.4

1.3

1.4

3.44

1023

4542

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

308

1110

1.57

11.55

2.3

2.5

u/ml

4534.0

982.8

0.36

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

565

2304

1.39

11.42

1.4

1.3

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

346

1284

1.53

11.41

1.5

1.3

—

(3022313) Gas panel - Capillary blood

806

3474

1.32

11.39

3.1

—

(3017181) Myelocytes/100 leukocytes in Blood

1799

8531

1.20

11.12

4.0

3.9

1.1

0.6

6.21

476

1553

(46235355) HIV 1 and 2 tests - Meaningful Use set

3224

20482

0.87

11.12

1.8

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

341

1271

1.52

11.04

1.5

1.3

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

396

1527

1.47

10.89

1.5

1.7

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

351

1321

1.50

10.86

1.5

1.3

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

395

3174

0.70

10.80

1.3

2.1

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

339

1269

1.51

10.77

1.5

1.3

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

580

2401

1.37

10.74

3.6

1.6

mg/l

32.2

34.7

0.24

462

1952

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

715

3057

1.33

10.72

3.3

3.2

mmol/l

25.2

25.0

0.70

653

2797

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

576

2387

1.37

10.60

1.3

1.2

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

3841

19397

1.14

10.57

3.2

3.3

ng/l

247.1

337.1

1.03

2581

12715

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

340

1281

1.50

10.49

1.5

1.3

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

218

740

1.67

10.44

3.8

2.7

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

704

3016

1.32

10.42

1.3

u/l

31.0

29.0

0.78

587

2358

(3034860) Kappa light chains.free [Mass/volume] in Serum

580

2415

1.36

10.37

3.6

1.6

mg/l

40.3

38.8

0.18

465

1967

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

252

2.17

10.30

2.0

1.4

—

(3002179) Metamyelocytes/100 leukocytes in Blood

1660

7870

1.20

10.29

3.8

3.7

0.7

0.5

1.28

352

1164

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

191

628

1.72

10.27

2.8

2.4

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

562

2332

1.37

10.27

3.5

1.6

ratio

1.7

1.5

0.23

214

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

772

3358

1.30

10.26

1.8

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

4765

24444

1.12

10.09

1.6

pmol/l

32147848.6

39484035.2

0.37

3935

20720

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

3.63

10.08

2.4

2.0

pmol/l

59.8

57.1

0.08

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

122

2.73

10.06

1.3

1.1

—

(3007164) IgA [Mass/volume] in Serum or Plasma

4942

25410

1.12

10.05

1.4

g/l

2.2

2.72

2964

15648

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

790

3457

1.30

10.04

1.7

g/l

1.5

0.06

665

2971

(3029937) Albumin [Presence] in Urine by Test strip

5978

31065

1.11

10.00

4.3

4.0

estimate

0.0

0.15

2188

10287

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

412

1629

1.43

9.98

1.6

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

432

1723

1.42

9.98

1.3

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

245

2.17

9.93

2.0

1.3

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

245

2.17

9.93

2.0

1.3

—

(40760888) Immunoglobulin light chains.free panel - Serum

440

1763

1.41

9.91

3.5

1.6

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

229

802

1.61

9.75

5.8

6.0

mg/l

11.8

0.03

209

724

(3004588) Protein electrophoresis panel - Serum or Plasma

1255

5826

1.22

9.65

2.3

1.5

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

544

2271

1.36

9.60

2.5

2.7

—

(3036489) Thrombin time

863

3843

1.27

9.59

1.8

1.9

21.2

20.9

0.61

726

3194

(3021440) Promyelocytes/100 leukocytes in Blood

1724

8257

1.19

9.56

4.1

4.0

0.2

0.1

3.77

445

1453

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

383

1507

1.44

9.55

1.3

1.2

—

(3003434) Protein [Mass/volume] in Pleural fluid

165

532

1.75

9.54

1.4

g/l

34.1

29.9

2.83

149

465

(3023323) Follitropin [Units/volume] in Serum or Plasma

2213

10833

1.17

9.42

1.3

iu/l

31.4

0.03

1951

9600

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

136

415

1.85

9.39

1.6

1.7

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

414

1660

1.41

9.32

1.3

1.2

nmol/l

0.6

1.5

0.72

396

1598

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

332

1279

1.47

9.25

1.4

1.5

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

1110

7579

0.82

9.09

1.4

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

247

898

1.55

9.04

1.5

1.4

—

(3010421) pH of Blood

522

2187

1.35

9.04

3.0

3.2

7.4

0.25

436

1783

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

412

1664

1.40

8.92

1.3

1.2

nmol/l

0.4

0.2

0.68

(40760892) CBC W Ordered Manual Differential panel - Blood

5275

27372

1.11

8.92

4.1

4.0

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

2684

13377

1.15

8.92

6.0

5.7

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

1273

5974

1.21

8.81

2.4

2.3

—

(3012544) pH of Venous blood

1627

7810

1.19

8.80

3.7

3.5

7.4

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

2262

11153

1.16

8.75

2.1

1.8

nmol/l

365.7

367.3

0.13

2082

10204

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1576

7551

1.19

8.71

3.8

3.5

kpa

5.8

5.9

1.93

1540

7315

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

4.23

8.67

1.9

3.9

mg/l

1.0

1.7

1.58

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

2266

14509

0.87

8.63

1.8

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

374

1496

1.41

8.58

5.0

5.3

iu/ml

583.0

950.2

0.55

202

(3012501) Base excess in Blood by calculation

444

1830

1.37

8.55

3.2

3.3

mmol/l

2.5

0.03

322

1214

(3013290) Carbon dioxide [Partial pressure] in Blood

444

1831

1.37

8.52

3.2

3.3

kpa

5.0

0.05

436

1784

(3027315) Oxygen [Partial pressure] in Blood

447

1847

1.37

8.48

3.2

3.3

kpa

8.7

0.20

439

1800

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

363

1449

1.42

8.43

1.4

1.3

pmol/l

297.9

296.4

0.03

287

1127

(3012441) Differential panel - Pleural fluid

124

382

1.83

8.37

1.5

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

163

2.32

8.36

1.7

1.4

u/l

22.8

29.5

0.21

140

(3000494) Fungus identified in Specimen by Culture

2613

13059

1.14

8.33

1.4

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

5276

27476

1.10

8.23

3.7

—

(40767503) Oxygen content in Capillary blood by calculation

414

1699

1.38

8.20

2.4

2.3

16.3

16.5

0.43

213

832

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

297

1149

1.46

8.16

1.2

u/l

58.2

56.6

0.22

200

784

(3002032) Base excess in Venous blood by calculation

1561

7523

1.18

8.07

3.8

3.5

mmol/l

2.0

2.1

0.23

1317

6215

(3000570) Elastase.pancreatic [Mass/mass] in Stool

710

3158

1.27

8.04

1.4

1.3

ug/g

301.0

303.1

0.09

389

1735

(3024354) Oxygen [Partial pressure] in Venous blood

1321

6280

1.20

7.99

3.1

3.0

kpa

4.5

0.25

1286

6075

(3023199) Leukocytes [#/volume] in Pleural fluid

151

501

1.70

7.99

1.4

e6/l

1914.7

3849.1

1.01

107

364

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

194

691

1.59

7.82

1.8

1.4

—

(21494755) Public health laboratory ask at order entry panel

2320

14726

0.88

7.75

1.3

—

(3028271) Lactate [Moles/volume] in Capillary blood

322

1279

1.42

7.73

1.7

mmol/l

1.6

1.7

1.93

316

1252

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

200

720

1.57

7.71

1.6

1.5

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

2003

12834

0.87

7.69

1.8

—

(3037756) Immunofixation for Serum or Plasma

362

1471

1.39

7.64

1.8

1.3

—

(3011985) Renin [Units/volume] in Plasma

382

1574

1.37

7.43

1.5

1.6

mu/l

51.8

53.5

0.08

352

1416

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

627

0.46

7.31

1.5

1.2

—

(3047189) Immunofixation for 24 hour Urine

215

2.05

7.29

2.0

1.3

—

(3045424) Erythrocytes [Presence] in Urine

464

1977

1.33

7.28

1.6

1.5

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

363

1493

1.38

7.16

3.2

3.3

nmol/l

0.8

1.05

277

1175

(3000475) Leukocytes [#/volume] in Synovial fluid

590

2607

1.28

7.09

1.7

e6/l

8535.4

10181.2

0.60

439

1898

(3028308) Erythrocytes [#/volume] in Pleural fluid

132

437

1.71

7.09

1.4

e6/l

35520.8

43311.4

0.17

248

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

210

781

1.52

7.06

1.8

1.3

—

(3025159) Blasts/100 leukocytes in Blood

1631

7976

1.16

7.06

4.1

4.0

0.4

0.1

0.55

388

1269

(3011288) Drugs identified in Urine by Screen method

375

2826

0.74

7.03

1.4

2.7

—

(3017732) Neutrophils [#/volume] in Blood

1761

8671

1.15

6.95

2.7

2.5

e9/l

4.0

0.03

1370

6933

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

661

4627

0.80

6.94

2.0

1.9

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

1067

5044

1.20

6.91

2.1

u/l

40.4

40.0

0.20

948

4600

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1030

4855

1.20

6.88

2.5

2.3

e6/l

0.2

0.3

0.54

988

4628

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

111

353

1.77

6.86

1.8

1.3

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

111

353

1.77

6.86

1.8

1.3

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

111

353

1.77

6.86

1.8

1.3

—

(3036603) Volume of Urine

176

634

1.57

6.83

1.5

1764.5

1940.4

0.65

137

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

533

2337

1.29

6.82

2.4

—

(3037121) Protein [Mass/volume] in Urine

667

3007

1.26

6.82

2.7

2.5

g/l

0.3

0.64

224

869

(3045788) Cell count panel - Pleural fluid

120

392

1.73

6.78

1.5

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

145

499

1.64

6.77

1.5

1.4

—

(3036670) Protein [Mass/volume] in Synovial fluid

253

1.92

6.76

1.2

1.3

g/l

38.1

37.6

0.14

132

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1121

5340

1.19

6.68

1.5

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

111

356

1.76

6.68

1.8

1.3

—

(3035637) Corticotropin [Mass/volume] in Plasma

277

1104

1.42

6.60

1.7

1.5

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

235

909

1.46

6.57

1.4

1.3

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

1885

9367

1.14

6.55

2.4

2.3

au/ml

23.5

24.9

0.16

669

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

815

0.55

6.47

1.4

—

(3000093) Morphology [Interpretation] in Blood Narrative

190

706

1.52

6.46

1.1

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

161

2.14

6.41

1.2

—

(3019060) Gas panel - Arterial blood

1082

5166

1.19

6.31

4.6

4.4

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

233

1.91

6.20

4.3

2.7

—

(1616796) Gas panel - Central venous blood

413

1774

1.32

6.20

3.1

3.0

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

1079

5160

1.19

6.18

3.0

3.1

g/l

127.9

129.0

0.91

1049

5037

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

1756

8723

1.14

6.14

2.4

2.2

ml/min/173m2

70.5

69.4

0.39

695

3387

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

255

1016

1.42

6.13

1.4

1.3

—

(3036782) Glucose [Moles/volume] in Pleural fluid

132

456

1.63

6.12

1.3

1.2

mmol/l

6.5

6.8

0.57

119

418

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

2825

17484

0.90

6.11

1.6

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

610

2763

1.25

6.04

1.5

1.4

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

338

1416

1.35

6.02

1.4

1.3

nmol/l

41.3

23.5

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

168

618

1.53

6.01

1.6

1.3

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

168

618

1.53

6.01

1.6

1.3

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

168

618

1.53

6.01

1.6

1.3

—

(3021788) Differential panel - Synovial fluid

450

1967

1.29

5.96

1.5

—

(3048689) Calprotectin [Mass/mass] in Stool

3265

16853

1.10

5.94

2.1

2.2

ug/g

110.8

107.5

0.23

2545

13080

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

319

1.75

5.92

1.6

1.3

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

812

3803

1.21

5.86

1.9

2.0

iu/l

4.5

16.9

1.18

321

1534

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

693

3195

1.23

5.85

2.2

mg/l

10.5

10.3

0.30

641

2989

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

846

3991

1.20

5.67

2.9

2.8

1.2

1.3

0.55

841

3970

(3042301) Urate [Moles/volume] in Synovial fluid

5.26

5.67

1.0

umol/l

316.0

308.2

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

110

371

1.67

5.63

1.5

1.3

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

100

330

1.71

5.54

1.6

1.3

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

104

347

1.69

5.54

1.3

1.2

u/l

305.3

384.9

0.49

321

(3042631) Mycobacterium sp identified in Specimen

225

894

1.42

5.54

2.6

2.8

—

(21494434) Karyotype in Bone marrow

146

531

1.55

5.53

1.3

1.1

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

3.32

5.52

1.0

1.1

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

611

2800

1.23

5.49

2.2

1.5

g/l

0.5

0.4

0.57

507

2423

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

482

2157

1.26

5.35

3.0

2.8

mg/l

1.5

1.4

0.36

438

1991

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

174

663

1.48

5.34

1.3

1.2

u/l

80.8

84.2

0.22

155

577

(21494814) CD8 cells/100 lymphocytes in Specimen

271

1.77

5.31

2.1

1.8

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

263

1.78

5.30

1.2

u/l

12.2

0.01

225

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

126

448

1.59

5.28

1.1

97.9

96.5

0.14

194

(3026726) Creatinine [Moles/volume] in Specimen

3.52

5.21

1.5

4.0

umol/l

776.4

284.2

0.87

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

3.52

5.21

1.6

1.9

5.8

7.8

—

(40765096) Chromosome analysis panel by Banding

104

2.28

5.19

1.2

1.0

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

1714

8601

1.13

5.17

1.3

au/ml

54.1

44.6

0.66

369

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

820

0.60

5.17

10.6

12.3

mmol/l

0.6

0.07

752

(3017354) Segmented neutrophils/100 leukocytes in Blood

184

715

1.45

5.13

3.0

2.5

56.2

59.7

1.09

135

460

(3025941) Bacteria identified in Stool by Culture

1486

7395

1.14

5.10

1.2

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

825

3925

1.19

5.09

2.8

0.7

0.51

799

3738

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

170

652

1.47

5.07

1.3

1.2

u/l

19.1

21.0

0.24

146

555

(1761482) Bacteria [#/volume] in Urine by Culture

535

2440

1.24

5.06

4.0

4.3

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

138

507

1.54

5.04

1.4

1.2

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

162

1.98

5.04

1.1

pmol/l

25.8

3.2

—

(3010838) Calcium [Moles/time] in 24 hour Urine

164

626

1.48

5.02

1.8

1.5

mmol/24h

6.6

5.2

0.41

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

2.94

5.00

1.3

1.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

1193

7683

0.87

4.98

1.5

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

128

464

1.56

4.97

1.1

113.4

116.3

0.41

112

416

(3021901) Oxygen saturation in Capillary blood

321

1377

1.32

4.96

2.6

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

212

1642

0.72

4.91

1.7

2.0

umol/l

6.7

6.2

0.23

155

1177

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

136

502

1.53

4.88

1.4

1.2

—

(21494890) Protein electrophoresis panel - 24 hour Urine

166

639

1.47

4.88

2.4

1.4

—

(3043410) Blood group antigens tested for on Red Blood Cells

204

1.85

4.88

1.4

1.6

—

(3028626) Oxygen [Partial pressure] in Capillary blood

375

1648

1.29

4.86

2.6

2.5

kpa

8.4

8.3

0.25

350

1528

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

5042

26753

1.08

4.81

1.3

iu/ml

28.3

35.0

1.56

1653

8774

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

772

3673

1.19

4.78

4.9

4.0

mmol/l

24.4

0.15

717

3259

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

269

1135

1.34

4.68

1.4

1.3

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

5797

30943

1.07

4.67

1.3

u/ml

1.3

1.5

0.69

1556

8984

(3028707) Methadone [Presence] in Urine by Screen method

238

1794

0.74

4.63

1.4

2.6

—

(3016228) CD19 cells/100 cells in Blood

279

1.70

4.62

2.1

1.8

9.1

8.4

0.17

270

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

125

459

1.54

4.62

1.1

91.8

94.5

0.46

197

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

105

370

1.60

4.62

1.4

1.2

—

(3013862) HLA-DP [Type]

4.58

4.61

1.1

1.0

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

711

3372

1.19

4.58

4.5

4.3

0.9

0.33

666

3173

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

280

1193

1.33

4.57

1.2

u/l

39.0

21.5

1.20

250

1039

(3009466) Valproate [Moles/volume] in Serum or Plasma

220

1674

0.74

4.57

5.5

5.4

umol/l

371.8

383.5

0.58

191

1475

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

105

371

1.60

4.57

1.4

1.2

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

164

639

1.45

4.57

1.5

1.9

101.2

101.8

0.08

147

577

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

376

1668

1.27

4.55

1.1

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

122

2.08

4.54

5.7

1.3

u/l

51.9

37.1

0.48

(3045414) Leukocytes [Presence] in Urine

1135

5593

1.15

4.54

1.9

1.8

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

161

626

1.45

4.53

1.6

1.7

125.2

129.5

0.33

152

589

(3052851) Hemolysis interference index of Serum or Plasma

636

2990

1.20

4.51

2.8

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

718

3416

1.19

4.48

4.4

4.2

1.5

1.7

4.18

669

3214

(3035880) pH of Pleural fluid

223

1.77

4.46

1.2

1.1

—

(21494815) CD4 cells/100 lymphocytes in Specimen

161

629

1.44

4.43

2.1

1.9

46.9

47.1

0.02

105

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

700

3326

1.19

4.43

2.1

1.4

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

669

3166

1.20

4.43

2.2

1.4

g/l

3.0

0.12

496

2456

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

701

3335

1.19

4.38

2.1

1.4

g/l

7.5

7.4

0.99

514

2486

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

2.48

4.32

4.0

1.8

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

2.88

4.30

1.7

1.2

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

174

694

1.42

4.30

1.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

751

3603

1.18

4.27

1.2

—

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

3.27

4.27

1.3

u/field

1.1

1.3

0.40

(4146454)

228

953

1.35

4.26

2.7

—

(3028433) Virus identified in Specimen by Culture

286

1.66

4.26

1.2

1.1

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

697

3326

1.19

4.22

2.1

1.4

g/l

3.7

0.18

485

2381

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

264

1130

1.32

4.22

1.0

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

345

1.59

4.15

2.8

2.6

43.4

46.0

0.48

128

(3020650) Glucose [Presence] in Urine

293

1.64

4.12

1.4

1.6

—

(3033799) Differential panel - Peritoneal fluid

139

1.95

4.10

2.3

2.1

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

233

985

1.34

4.07

1.4

e6/l

84889.9

80330.2

0.04

155

677

(42529406) Shigella sp [Presence] in Stool by Culture

757

3653

1.17

4.03

1.2

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

1025

5062

1.15

4.01

6.7

6.4

mmol/l

24.7

0.05

951

4681

(3014765) Yersinia sp identified in Stool by Organism specific culture

756

3650

1.17

4.01

1.2

—

(3044941) Cell count panel - Synovial fluid

370

1669

1.25

3.96

1.4

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

846

4125

1.16

3.96

3.0

2.9

mmol/l

25.5

0.01

825

3993

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

2.89

3.94

2.0

62.5

63.1

0.02

(46236302) HLA-C [Type] by High resolution typing

4.23

3.92

1.1

1.0

—

(40760409) HLA-A [Type] by High resolution

4.23

3.92

1.1

1.0

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

4.23

3.92

1.0

—

(40760410) HLA-B [Type] by High resolution

4.23

3.92

1.1

1.0

—

(40763590) HLA-DQ beta [Type]

4.23

3.92

1.1

1.0

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

4814

25677

1.07

3.90

1.3

u/ml

8.3

11.6

3.42

1895

10659

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

308

1362

1.28

3.89

1.4

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1557

7911

1.12

3.87

1.4

—

(1761868) Lipid panel - Serum or Plasma

8751

47546

1.06

3.85

2.8

2.6

—

(3003338) MCHC [Mass/volume]

18563

106179

0.94

3.85

16.6

13.6

g/l

330.5

331.1

19.55

18441

105423

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

168

683

1.39

3.78

1.6

1.5

u/l

5.0

6.4

0.55

331

(3044927) Protein electrophoresis panel - Urine

193

804

1.35

3.75

1.2

—

(3039000) Anion gap in Blood

388

1778

1.23

3.64

5.8

5.7

mmol/l

11.1

0.00

346

1602

(3011412) CD3 cells [#/volume] in Blood

191

799

1.35

3.62

2.4

2.2

e9/l

1.2

1.3

0.20

116

442

(3018572) Chloride [Moles/volume] in Blood

388

1779

1.23

3.62

5.8

5.7

mmol/l

105.2

104.9

0.56

346

1603

(3012565) Volume of 24 hour Urine

122

472

1.46

3.62

2.1

1.8

1821.2

2032.5

1.86

113

431

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

322

1.56

3.60

1.4

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

322

1.56

3.60

1.4

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

200

1.72

3.60

2.1

1.7

—

(3044007) Cell count panel - Peritoneal fluid

138

1.88

3.60

2.4

2.2

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

226

1.67

3.58

1.3

1.4

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

644

3101

1.17

3.57

2.1

1.4

g/l

10.0

10.2

0.44

523

2591

(3008037) Lactate [Moles/volume] in Venous blood

412

1907

1.22

3.53

2.7

2.8

mmol/l

1.5

0.56

402

1870

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

551

2622

1.19

3.52

2.0

1.4

g/l

38.1

38.3

0.42

459

2235

(3006184) Hemoglobin [Mass/volume] in Capillary blood

438

2041

1.21

3.51

2.1

2.0

g/l

129.7

129.6

0.02

308

1480

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

302

1.57

3.50

2.9

—

(40758292) HTLV I+II Ab panel - Serum

2.25

3.49

1.5

1.2

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

339

1.53

3.46

1.5

1.6

ug/l

0.4

0.55

224

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

139

557

1.41

3.44

2.7

2.4

e6/l

716.7

1044.6

1.05

257

(3013139) Helicobacter pylori Ag [Presence] in Stool

1893

9783

1.10

3.41

1.2

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

315

2196

0.81

3.40

1.0

1.1

u/ml

4.1

3.9

0.04

104

769

(3023487) Leukocytes [#/volume] in Peritoneal fluid

174

1.75

3.40

2.4

2.3

e6/l

677.2

721.5

0.05

122

(3020876) Protein [Mass/time] in 24 hour Urine

148

601

1.39

3.40

2.0

1.7

g/24h

0.7

1.2

0.78

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

305

1373

1.25

3.39

1.6

50.4

51.7

0.23

198

829

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

219

1591

0.77

3.37

1.2

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

2.62

3.37

1.3

1.0

—

(4094501)

622

3003

1.17

3.36

1.1

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

135

541

1.41

3.35

1.1

u/l

78.4

77.5

0.05

114

416

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

2.37

3.34

1.1

1.2

—

(3000330) Specific gravity of Urine by Test strip

1084

5444

1.13

3.34

3.3

3.2

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

2297

13948

0.92

3.33

1.3

1.4

—

(3008536) Aspergillus sp Ab [Presence] in Serum

110

1.95

3.32

2.0

1.5

—

(3000012) Reticulocyte production index

108

418

1.46

3.24

1.4

1.3

—

(1002224) Polysomnography panel

1118

5639

1.12

3.22

1.1

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

426

1999

1.20

3.21

2.7

mmol/l

25.1

25.0

0.12

379

1745

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

7.89

3.16

1.1

1.0

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

7.89

3.16

1.0

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

134

543

1.39

3.15

1.1

u/l

21.5

18.6

0.26

108

402

(3017143) Hepatitis C virus Ab [Presence] in Serum

2405

12610

1.08

3.12

1.6

1.5

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

133

1.82

3.12

1.3

63.8

54.7

0.87

108

(40761539) Cells [Type] in Urine sediment by Light microscopy

192

1.67

3.11

1.2

1.1

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

775

3829

1.14

3.11

3.6

3.5

48.3

47.8

0.24

767

3788

(3020891) Body temperature

677

3313

1.16

3.10

4.6

4.4

—

(3038515) Glucose [Moles/volume] in Venous blood

386

1805

1.21

3.04

2.8

2.9

mmol/l

7.4

0.02

377

1771

(3003327) Ova and parasites identified in Stool by Light microscopy

929

4652

1.13

3.04

1.8

1.7

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

364

2468

0.83

3.03

1.1

u/ml

2.0

1.7

0.11

551

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

527

2537

1.17

3.00

2.1

1.4

g/l

0.0

0.20

469

2325

(3024980) IgG subclass 4 [Mass/volume] in Serum

407

1916

1.20

2.99

1.5

g/l

0.6

0.06

289

1482

(3023183) Ammonium ion [Moles/volume] in Plasma

317

1457

1.23

2.97

2.9

umol/l

32.6

32.7

0.03

266

1262

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

485

2321

1.18

2.97

2.1

1.4

g/l

0.0

0.50

430

2116

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

152

1.74

2.97

1.1

1.2

nmol/l

0.4

0.13

(3024928) Oxygen saturation in Venous blood

358

1667

1.21

2.96

3.4

3.6

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

266

1.55

2.94

1.1

86.8

94.9

0.39

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

148

618

1.35

2.92

1.9

1.8

14.4

13.4

0.45

338

(3026692) Albumin [Mass/volume] in Peritoneal fluid

132

1.79

2.92

1.4

g/l

14.8

10.3

1.62

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

367

1.46

2.92

1.3

1.4

u/l

12.2

12.4

0.07

356

(3033705) Calcium.ionized [Moles/volume] in Venous blood

232

1032

1.27

2.91

1.9

2.2

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

563

2733

1.16

2.90

2.1

ug/l

546.8

487.4

0.13

512

2495

(4010399)

1652

8554

1.09

2.90

1.4

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

2.54

2.88

3.9

1.2

—

(40761535) Cells panel - Urine sediment

1722

8938

1.09

2.86

3.4

3.5

—

(4198724)

447

0.62

2.83

1.2

2.2

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

121

492

1.39

2.83

1.1

1.0

—

(3047181) Lactate [Moles/volume] in Blood

555

2702

1.16

2.77

4.9

4.8

mmol/l

1.3

1.2

0.13

489

2389

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

112

452

1.40

2.74

1.7

142.2

148.4

0.33

104

417

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

157

1.69

2.69

2.3

2.0

e6/l

28656.8

16737.9

0.21

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

568

2779

1.15

2.67

1.6

1.5

iu/ml

21.4

17.1

0.25

(3024263) Appearance of Synovial fluid

128

532

1.36

2.64

2.0

1.8

—

(3048879) Bone marrow aspiration report

171

1.65

2.63

2.0

1.3

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

475

2297

1.17

2.61

2.2

1.4

g/l

0.0

0.00

428

2109

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

354

1.43

2.56

2.3

2.4

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

4.51

2.55

1.0

1.2

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

165

0.41

2.54

1.1

1.2

—

(3009015) Lactate [Moles/volume] in Synovial fluid

1.86

2.52

1.3

mmol/l

5.5

5.1

0.22

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

268

1.49

2.49

1.1

67.9

78.2

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

260

1.50

2.45

1.1

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

390

1869

1.18

2.42

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

390

1869

1.18

2.42

1.3

—

(3040151) Glucose [Moles/volume] in Capillary blood

212

957

1.25

2.42

3.4

8.1

mmol/l

7.4

0.00

174

770

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

684

3416

1.13

2.41

1.3

u/ml

46.6

45.0

0.09

358

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

136

580

1.32

2.41

2.0

1.9

—

(3032057) Clostridioides difficile [Presence] in Stool

216

1.54

2.39

1.8

1.6

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

124

1.73

2.39

1.1

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

285

1926

0.83

2.38

1.2

1.3

mmol/l

7.3

7.2

0.36

207

1409

(3027923) C peptide [Moles/volume] in Serum or Plasma

124

523

1.34

2.37

1.5

1.8

nmol/l

1.2

1.3

0.52

431

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

211

955

1.25

2.36

1.5

g/l

1.0

0.9

0.93

211

948

(3003888) Timothy IgE Ab [Units/volume] in Serum

406

2661

0.86

2.35

1.1

u/ml

2.7

3.7

1.02

167

1264

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

800

4041

1.12

2.35

1.3

u/ml

8.8

7.1

0.28

141

672

(4212803)

2.11

2.34

1.0

1.1

—

(44806118)

193

866

1.26

2.33

1.5

—

(44790049)

193

866

1.26

2.33

1.5

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

104

1.79

2.33

1.2

1.1

mmol/l

2.2

1.9

0.43

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

2.07

2.32

1.2

1.3

ug/l

1336.0

44.1

0.64

(3008401) Mugwort IgE Ab [Units/volume] in Serum

386

2536

0.86

2.32

1.1

u/ml

0.9

0.8

0.07

130

969

(44790048)

193

867

1.26

2.31

1.5

—

(44790047)

193

867

1.26

2.31

1.5

—

(3014271) Vancomycin [Susceptibility]

381

1.39

2.31

2.7

3.0

—

(3023511) Choriogonadotropin [Units/volume] in Urine

467

3024

0.87

2.31

1.2

1.3

—

(3022475) Manganese [Moles/volume] in Blood

1.90

2.29

1.3

1.2

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1401

7286

1.09

2.29

1.1

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

785

4917

0.90

2.28

1.4

1.3

miu/ml

213.5

223.5

0.35

367

2483

(3006922) Hepatitis E virus Ab [Presence] in Serum

174

774

1.27

2.27

1.1

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

2.28

2.25

1.1

1.0

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

811

4114

1.11

2.22

1.4

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

454

2935

0.87

2.21

1.1

u/ml

1.6

1.2

0.25

149

1048

(3023430) Cat dander IgE Ab [Units/volume] in Serum

310

2059

0.85

2.16

1.0

1.1

u/ml

3.9

3.7

0.09

105

787

(3032868) Hemoglobin electrophoresis panel in Blood

1.96

2.15

1.5

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

358

1724

1.17

2.14

1.1

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

524

0.70

2.14

1.2

—

(4024509)

237

1100

1.22

2.13

1.7

1.6

—

(3026250) Tacrolimus [Mass/volume] in Blood

354

1.39

2.12

32.8

36.3

ug/l

7.2

0.02

329

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

378

1.37

2.11

2.3

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

784

3984

1.11

2.10

1.3

u/ml

3.6

6.5

1.01

429

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

865

4419

1.11

2.10

1.3

u/ml

29.0

39.7

0.53

308

(3022621) pH of Urine by Test strip

1515

7937

1.08

2.09

3.1

2.9

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

108

1.72

2.09

1.6

1.5

g/l

23.8

21.6

0.30

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

386

1875

1.16

2.08

1.4

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

295

0.61

2.03

2.0

1.9

umol/l

17.3

17.2

0.02

295

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

230

1071

1.21

2.02

1.2

1.1

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

2.01

2.00

1.1

1.0

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

735

3734

1.11

2.00

1.2

—

(3037522) Nuclear Ab [Titer] in Serum

3679

19852

1.05

2.00

1.4

titre

502.6

620.5

3.54

781

4315

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

196

900

1.23

1.98

1.3

1.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

195

895

1.23

1.98

1.3

1.2

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

136

1.62

1.98

1.5

1.4

pmol/l

59.5

41.3

0.29

111

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

1.76

1.98

1.7

2.2

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

110

1.69

1.98

1.1

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

123

1.65

1.98

1.1

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

398

1947

1.15

1.97

1.2

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

180

820

1.24

1.96

1.3

g/l

1.5

—

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

2.13

1.95

1.1

1.0

u/field

1.9

1.3

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

115

1.67

1.94

1.2

1.1

—

(3006270) Folate [Moles/volume] in Blood

218

1015

1.21

1.94

1.2

1.1

nmol/l

373.4

390.2

0.60

194

884

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

137

1.60

1.93

1.1

1.0

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

2.02

1.93

1.1

1.0

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

409

1.34

1.92

1.1

1.2

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

266

1.42

1.90

3.3

2.7

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

588

2960

1.12

1.90

1.1

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

864

4440

1.10

1.89

1.5

u/ml

11.9

11.8

0.00

100

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

15282

87263

0.97

1.89

3.1

3.3

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

269

1782

0.85

1.86

1.0

u/ml

0.1

0.4

1.04

318

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

181

831

1.23

1.86

1.5

1.4

nmol/l

1.7

1.5

1.19

163

750

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

1.85

1.1

1.0

u/ml

0.1

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

1.94

1.85

1.3

1.2

13.8

13.1

0.04

(4211845)

135

600

1.27

1.84

4.1

2.8

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

389

0.68

1.84

2.0

2.4

nmol/l

154.7

164.7

0.28

348

(3000919) Neutrophils/100 leukocytes in Pleural fluid

104

1.68

1.84

1.3

23.9

25.8

0.12

(3043409) Potassium [Moles/volume] in Arterial blood

493

2462

1.13

1.83

4.4

4.2

mmol/l

3.8

0.24

470

2325

(3025315) Body weight

1.80

4.4

3.9

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.83

1.79

1.6

1.2

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1412

7431

1.07

1.78

2.1

2.2

ug/l

5.5

6.0

0.51

1161

6420

(3018405) Lactate [Moles/volume] in Arterial blood

554

2793

1.12

1.77

4.1

4.0

mmol/l

1.3

0.12

542

2745

(3024869) Neuronal Ab [Presence] in Serum

132

1.58

1.75

1.1

1.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

154

701

1.24

1.74

1.1

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

163

747

1.23

1.73

1.6

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

469

0.72

1.72

1.2

—

(3023383) Lactate [Moles/volume] in Pleural fluid

124

1.59

1.71

1.3

1.2

mmol/l

3.1

3.2

0.05

114

(37021550) Renin [Units/volume] in Plasma --upright

241

1.40

1.64

1.4

1.3

mu/l

60.1

57.7

0.05

183

(3047007) Chlamydophila sp Ab [Presence] in Serum

424

2115

1.13

1.64

1.3

1.2

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

294

1.36

1.63

1.4

1.3

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

323

1583

1.15

1.63

1.1

iu/ml

34.7

8007.5

0.65

341

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

154

707

1.23

1.63

1.1

—

(3035320) C reactive protein [Mass/volume] in Body fluid

182

850

1.21

1.62

2.3

2.5

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

1434

7579

1.07

1.62

2.6

ng/l

160.4

161.2

0.02

1298

6869

(3035933) Granulocytes/100 leukocytes in Blood

304

1.35

1.62

1.3

2.1

—

(3006462) Nitrate [Presence] in Urine

123

551

1.26

1.62

4.2

2.8

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

4.02

1.61

1.0

1.1

nmol/24h

21.8

—

(3016244) Insulin [Units/volume] in Serum or Plasma

182

851

1.21

1.61

3.3

3.7

mu/l

28.4

30.3

0.23

172

818

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

437

0.72

1.61

1.8

1.7

ug/l

8.8

8.6

0.21

437

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

1031

5389

1.08

1.59

1.7

1.6

—

(3010375) cycloSPORINE [Mass/volume] in Blood

325

1.34

1.58

24.8

25.6

ug/l

117.0

118.4

0.07

267

(3004716) Salmonella sp identified in Stool by Organism specific culture

1366

7217

1.07

1.57

1.4

1.5

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

112

498

1.27

1.57

1.6

1.7

umol/l

2.0

0.15

105

465

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

373

1852

1.14

1.57

1.3

1.2

u/ml

293.6

283.6

0.29

237

1277

(3015171) Extractable nuclear Ab [Units/volume] in Serum

1204

6334

1.07

1.57

1.3

u/ml

1.4

0.8

0.60

119

552

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

295

0.67

1.55

1.2

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

2.30

1.52

1.2

1.1

—

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

1.79

1.49

1.1

1.0

u/ml

0.0

0.1

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

2.02

1.46

10.1

1.6

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

155

722

1.21

1.46

1.1

nmol/l

2.8

4.2

0.22

132

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

260

1687

0.87

1.45

1.4

1.6

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

1.67

1.44

3.0

3.1

mmol/l

0.5

1.2

1.83

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.78

1.42

1.2

1.1

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

131

602

1.23

1.41

1.8

1.6

nmol/l

2.6

11.8

0.51

116

485

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

416

2096

1.12

1.41

1.1

—

(3007566) Smooth muscle Ab [Titer] in Serum

658

3396

1.09

1.40

1.3

1.2

titre

136.7

142.2

0.06

295

(3018001) Oat IgE Ab [Units/volume] in Serum

121

0.51

1.39

1.1

1.0

u/ml

0.2

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.92

1.38

3.5

1.0

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

274

1.34

1.38

1.2

pmol/l

389.9

332.7

0.48

203

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

1.73

1.37

1.3

1.2

u/l

35.7

611.9

0.52

(3030313) Adrenal Ab [Titer] in Serum

149

0.57

1.36

1.1

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

399

2012

1.12

1.35

1.2

1.3

titre

132.0

86.5

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

378

2380

0.89

1.34

1.7

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

1.78

1.34

2.0

2.4

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

2.25

1.34

1.3

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

382

1923

1.12

1.33

1.1

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

142

1.47

1.33

5.6

5.3

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

347

1738

1.13

1.32

1.4

u/ml

125.6

114.6

0.40

423

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.98

1.30

1.2

1.1

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

189

908

1.17

1.30

1.1

mg/l

298.3

628.5

0.50

169

812

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

689

3579

1.09

1.29

1.7

1.6

titre

311.7

299.2

0.04

190

(3034770) Mitochondria Ab [Titer] in Serum

659

3417

1.09

1.29

1.2

titre

640.0

1053.5

1.52

160

(3000034) Microalbumin [Mass/volume] in Urine

199

962

1.17

1.27

2.5

2.8

mg/l

35.5

40.6

0.12

129

642

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

137

641

1.21

1.27

1.3

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

131

611

1.21

1.26

2.5

2.2

e9/l

0.2

0.84

118

515

(3051593) INR in Capillary blood by Coagulation assay

363

1.27

1.25

8.3

8.9

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

176

1159

0.85

1.24

1.3

u/ml

0.5

1.1

1.23

487

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

0.52

1.24

1.0

u/ml

0.3

0.4

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

112

1.51

1.24

1.1

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

1.84

1.24

1.0

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

2.17

1.24

10.3

1.2

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

128

597

1.21

1.23

1.0

95.0

95.2

0.02

468

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

176

845

1.17

1.23

1.1

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

173

1.40

1.23

1.3

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

130

0.56

1.23

2.6

2.3

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

466

2385

1.10

1.23

3.8

3.3

mg/l

23.5

22.9

0.11

294

1469

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

2.25

1.22

3.3

3.1

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

1.72

1.22

1.1

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

134

629

1.20

1.21

2.5

2.2

e6/l

446.8

525.5

0.63

118

518

(3001186) Copper [Moles/volume] in Serum or Plasma

320

1.29

1.21

1.3

1.4

umol/l

17.3

17.9

0.64

279

(3003157) Bacteria [#/volume] in Mother's milk

0.00

1.21

0.0

6.4

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

261

1.32

1.21

1.1

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

227

1.34

1.20

1.3

1.1

—

(40760866) Procollagen type III.N-terminal propeptide [Units/volume] in Serum

0.00

1.19

0.0

1.0

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

1037

5494

1.07

1.17

1.1

u/ml

0.9

3.1

0.95

(3014051) Protein [Presence] in Urine by Test strip

530

2737

1.09

1.17

2.1

2.0

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

453

1.23

1.16

1.1

1.2

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

1.83

1.16

1.2

1.4

nmol/l

560.5

423.0

0.50

(3009214) Lutropin [Units/volume] in Serum or Plasma

502

2588

1.09

1.15

1.2

u/l

18.5

14.4

4.89

425

2099

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

176

1.38

1.14

1.9

2.6

mmol/l

6.8

7.2

0.39

103

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1691

9096

1.05

1.13

1.6

1.7

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.56

1.12

1.6

—

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

2.32

1.11

1.0

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

118

0.57

1.09

1.5

1.2

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

1.68

1.08

1.8

1.4

—

(4306422)

379

1937

1.10

1.06

1.2

—

(3025577) Chromium [Mass/volume] in Blood

110

515

1.20

1.06

2.0

2.1

ug/l

2.5

3.0

0.62

435

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

157

759

1.17

1.05

1.1

u/l

1.0

1.1

0.61

313

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

1.55

1.05

1.1

1.2

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

389

1995

1.10

1.03

2.3

2.1

nmol/l

0.9

0.8

0.36

323

1678

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

1.75

1.03

2.1

5.1

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

142

683

1.17

1.02

1.5

1.4

ug/l

8.6

7.4

0.38

125

604

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.48

1.02

1.1

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

198

979

1.14

1.00

1.1

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

122

581

1.18

0.99

1.2

52.8

58.7

0.26

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

1.48

0.99

1.4

25.9

26.4

0.02

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

176

0.67

0.99

1.0

—

(3037556) Urate [Mass/volume] in Serum or Plasma

265

1.28

0.99

1.2

—

(3029396) Erythrocyte agglutination [Presence] in Blood

319

0.76

0.99

2.5

3.1

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

177

1.34

0.96

1.7

1.1

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

549

0.82

0.96

1.2

2.0

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

110

1.43

0.95

1.1

1.2

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

788

4716

0.94

1.6

mu/l

320.3

331.1

0.31

709

4196

(4062490)

253

1276

1.12

0.94

1.4

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.47

0.93

1.0

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

1.52

0.93

1.2

1.1

mmol/l

0.3

1.7

1.08

(36660697) Celiac disease serology panel - Serum

2024

10991

1.04

0.93

1.2

—

(40768446) Kidney Pathology biopsy report

323

1.24

0.93

1.9

1.6

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

131

633

1.17

0.92

1.7

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

203

1013

1.13

0.91

1.1

iu/ml

7.0

8.2

0.27

247

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

2306

13429

0.96

0.91

1.5

1.6

1.3

0.02

2048

11981

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

214

1.29

0.90

1.1

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

464

0.81

0.90

1.0

1.1

u/ml

10.9

8.0

0.22

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

178

882

1.14

0.89

1.3

mmol/l

2.1

2.0

0.33

167

818

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

111

0.61

0.89

9.3

7.2

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

152

745

1.15

0.89

1.4

u/l

5.3

0.03

132

608

(3028192) IgG subclass 2 [Mass/volume] in Serum

251

1271

1.11

0.89

1.4

g/l

2.9

3.0

0.37

165

928

(3024139) IgG subclass 3 [Mass/volume] in Serum

251

1272

1.11

0.88

1.4

g/l

0.4

0.07

168

933

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

275

1.25

0.88

1.3

1.4

42.8

41.9

0.06

189

(3017509) Phencyclidine [Presence] in Urine

124

0.64

0.87

1.4

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

213

1070

1.12

0.87

1.3

1.2

—

(3051611) Lipemic interference index of Serum or Plasma

200

1001

1.13

0.87

3.1

2.9

—

(3004451) EKG impression Narrative

373

1.21

0.85

1.2

1.3

—

(3034426) Prothrombin time (PT)

409

1.20

0.85

1.2

1.1

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

113

1.40

0.85

13.8

9.7

mmol/l

4.9

4.4

0.64

113

(3020123) Porphyrins [Interpretation] in Serum or Plasma

1.48

0.85

1.0

1.1

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

209

1051

1.12

0.85

1.3

1.2

titre

—

(3019977) pH of Arterial blood

415

1.20

0.84

3.1

2.6

7.4

0.23

119

(3049242) von Willebrand panel - Platelet poor plasma

1.82

0.83

2.3

1.4

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

462

1.18

0.83

1.1

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

1.66

0.83

1.0

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

1.59

0.82

1.3

1.2

ug/l

133.1

126.9

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

202

1016

1.12

0.82

1.1

—

(3011897) Casein IgE Ab [Units/volume] in Serum

246

0.76

0.82

1.2

u/ml

0.1

10.9

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

201

0.73

0.82

1.2

1.1

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

159

788

1.14

0.82

1.4

umol/l

10.5

11.0

0.53

152

752

(3027135) IgG subclass 1 [Mass/volume] in Serum

250

1273

1.11

0.82

1.4

g/l

6.5

6.7

0.29

164

930

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

284

0.77

0.82

1.3

mg/l

0.8

47.0

1.37

207

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

1.51

0.81

1.0

u/l

33.9

53.3

1.25

(21491868) Cryoglobulin [Mass/volume] in Serum

427

0.82

0.81

1.1

1.2

g/l

0.3

0.1

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.49

0.81

1.0

1.1

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

1.88

0.79

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

1.88

0.79

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

1.88

0.79

2.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

1.88

0.79

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

1.88

0.79

2.0

1.9

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

1.88

0.79

2.0

1.9

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

1.81

0.79

1.0

1.3

—

(3003721) Smooth muscle Ab [Units/volume] in Serum

110

1.38

0.79

1.1

u/ml

3.2

2.3

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

462

2423

1.08

0.79

1.2

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

283

1454

1.10

0.78

1.1

g/l

1.5

0.03

255

1305

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

158

787

1.13

0.77

3.9

3.8

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

325

0.80

0.77

1.0

1.1

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

128

629

1.15

0.76

1.3

u/l

267.7

287.2

0.09

120

589

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

111

1.37

0.76

1.1

—

(3013336) Amino acids [Identifier] in Serum or Plasma

2.17

0.76

4.0

1.5

—

(3051651) Icteric interference index of Serum or Plasma

462

1.17

0.75

3.4

3.3

—

(3026470) Cobalt [Mass/volume] in Blood

110

536

1.16

0.74

2.0

2.1

ug/l

3.3

4.3

0.69

101

475

(3044290) Cell count panel - Cerebral spinal fluid

469

2472

1.07

0.72

1.2

1.3

—

(3016018) Differential panel - Cerebral spinal fluid

246

1264

1.10

0.71

1.2

1.4

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

157

1.29

0.70

1.1

—

1.2

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

117

0.67

0.70

1.4

1.5

mg/l

1.0

2.3

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

580

3083

1.06

0.69

1.2

u/ml

19.9

12.6

—

(40765089) Chromosome analysis panel - Blood by G-banded

201

0.76

0.69

1.0

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

443

0.84

0.69

3.1

2.9

umol/l

28.6

27.7

0.17

333

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

239

1.23

0.68

1.1

—

(3020393) Adenovirus Ag [Presence] in Stool

1.43

0.67

1.0

—

(3026389) Candida sp identified in Specimen by Organism specific culture

389

2043

1.07

0.67

1.4

1.3

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

1.63

0.67

1.4

1.1

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

354

1855

1.08

0.66

1.1

125.1

123.0

0.59

320

1669

(3038071) Oxygen [Partial pressure] in Mixed venous blood

141

0.72

0.65

22.1

7.0

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

1.76

0.63

1.0

1.1

titre

1278.0

2342.5

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

423

1.16

0.63

1.1

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

210

1079

1.10

0.63

1.1

1.2

mg/l

41.0

37.6

0.31

172

907

(3006598) pH of Arterial cord blood

0.00

0.62

0.0

1.2

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

1.61

0.62

1.0

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

107

0.68

0.62

3.8

7.6

—

(40757494) Bilirubin.total [Moles/volume] in Blood

482

1.15

0.62

2.3

1.9

umol/l

20.0

14.3

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

600

3209

1.05

0.61

1.3

u/ml

6.8

6.6

0.02

245

(3017704) Immunofixation for Urine

409

1.16

0.61

1.8

1.3

—

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

113

0.70

0.60

1.4

1.5

mg/l

2.0

2.4

—

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

113

0.70

0.60

1.4

1.5

mg/l

1.4

2.7

—

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

113

0.70

0.60

1.4

1.5

mg/l

2.0

1.9

—

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

113

0.70

0.60

1.4

1.5

mg/l

0.8

1.0

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

136

1.28

0.60

1.6

2.4

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

136

1.28

0.60

1.2

ng/l

46.9

55.7

0.21

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

4611

26411

0.98

0.60

1.5

1.6

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

1.55

0.60

1.0

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

1.55

0.60

1.3

1.0

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.55

0.60

1.0

1.1

nmol/l

350.6

266.3

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

167

1038

0.91

0.60

1.4

1.3

mmol/l

11.9

11.2

0.32

216

(3020961) Endomysium IgA Ab [Titer] in Serum

1287

7006

1.04

0.60

1.1

titre

166.8

180.0

0.07

158

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

381

0.84

0.60

1.1

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

119

595

1.13

0.59

1.1

—

(3001019) Free T4 and TSH panel - Serum or Plasma

1709

9911

0.97

0.59

1.8

1.7

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

1.78

0.59

1.5

1.1

1.7

1.6

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

177

1.24

0.59

1.4

1.6

—

(3005322) IgE [Units/volume] in Serum or Plasma

1710

9358

1.03

0.58

1.3

u/ml

133.2

184.4

2.98

1581

8707

(3015076) Soybean IgE Ab [Units/volume] in Serum

136

852

0.90

0.57

1.0

u/ml

0.2

0.3

0.37

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

202

1042

1.09

0.57

1.1

mg/l

250.7

225.7

0.89

176

920

(44813793)

211

1092

1.09

0.56

1.1

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

565

0.88

0.56

1.2

g/l

0.3

0.42

446

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

425

2258

1.06

0.56

1.1

au/ml

18.0

11.0

0.57

140

(3034092) Cytoplasmic Ig cells/100 cells in Blood

158

1.25

0.56

5.3

8.0

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

128

1.28

0.55

1.1

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

1.41

0.55

2.5

1.5

umol/24h

417.2

272.1

1.36

(3017569) Oxygen content in Arterial blood

335

1.16

0.54

1.8

2.1

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

180

0.78

0.54

1.1

—

(3001556) Androgen free Index in Serum or Plasma

0.65

0.53

1.0

1.1

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

376

1994

1.06

0.53

1.3

u/ml

44.8

62.4

0.79

155

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

178

917

1.09

0.53

2.2

2.0

u/field

2.7

2.4

0.22

369

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

104

1.30

0.52

1.9

2.0

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

290

1527

1.07

0.52

1.2

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

226

1179

1.08

0.51

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

396

2108

1.06

0.51

1.1

—

(3002619) Bacteria identified in Specimen by Culture

217

1.19

0.50

1.3

—

(3016750) Collection duration of Urine

500

0.88

0.50

2.4

2.1

min

489.1

498.0

0.34

401

(3025018) Bordetella pertussis Ab [Titer] in Serum

179

926

1.09

0.50

1.3

1.2

—

(3003740) Influenza virus B Ag [Presence] in Specimen

396

2109

1.06

0.50

1.1

—

(3025130) Human papilloma virus identified in Specimen

488

2889

0.95

0.50

1.6

1.7

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

270

1.17

0.49

1.0

ug/l

82.0

80.4

0.11

225

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

1.52

0.48

1.1

1.0

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

128

654

1.10

0.47

2.7

2.4

u/ml

945.0

659.0

0.78

128

645

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

0.59

0.47

1.0

—

(40762814) Titanium [Mass/volume] in Blood

157

1.22

0.47

2.4

2.3

ug/l

2.9

4.4

1.32

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

109

553

1.11

0.46

1.3

1.8

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

431

2308

1.05

0.46

1.2

—

(4268621)

243

1279

1.07

0.46

2.4

2.2

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

1.38

0.45

1.9

1.4

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

1.50

0.44

1.4

1.1

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

107

666

0.90

0.44

1.6

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

156

0.79

0.44

18.5

7.3

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

1.66

0.44

1.0

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

1.66

0.44

1.0

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

0.70

0.44

1.0

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

137

0.78

0.43

1.1

1.0

—

(3024932) HLA-DR beta [Type]

263

1.16

0.43

1.2

1.1

—

(4015189)

242

1.16

0.43

2.2

2.7

—

(3020093) Fractional oxyhemoglobin in Venous cord blood

0.00

0.43

0.0

1.2

—

64.0

—

(3014345) clomiPRAMINE [Moles/volume] in Serum or Plasma

0.00

0.43

0.0

2.7

—

392.1

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

202

1060

1.07

0.43

1.5

1.6

45.0

34.5

3.09

126

622

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

1.41

0.43

1.8

1.7

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

1.41

0.42

1.1

1.3

—

(3034614) HLA Ag [Interpretation]

1.41

0.42

1.0

1.1

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

143

740

1.09

0.42

1.6

1.5

umol/l

60.0

63.8

—

(3022670) pH of Venous cord blood

0.00

0.42

0.0

1.2

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

861

4695

1.03

0.42

1.8

1.9

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

139

1.22

0.41

2.7

2.4

u/field

0.5

0.9

1.58

139

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

181

948

1.08

0.41

1.3

1.2

titre

146.8

187.1

0.40

168

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

291

1.14

0.41

1.3

nmol/l

134.8

121.3

0.31

209

(3024471) HLA-A [Type]

270

1.15

0.41

1.0

—

(3007919) Fasciola sp Ab [Titer] in Serum

1.48

0.40

1.0

1.1

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

478

1.11

0.40

1.2

nmol/l

59.8

59.9

0.01

471

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

462

1.11

0.40

1.1

ng/l

196.4

489.1

0.38

103

(3005082) Progesterone [Moles/volume] in Serum or Plasma

120

738

0.92

0.40

1.3

nmol/l

30.1

30.8

0.10

111

645

(3005011) Chlamydia sp Ab [Titer] in Serum

209

0.84

0.40

1.6

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

180

944

1.07

0.40

1.3

1.2

titre

314.0

120.3

—

(3036525) Urea [Moles/time] in 24 hour Urine

1.41

0.40

1.6

2.2

—

(3029075) Extractable nuclear Ab panel - Serum

409

1.12

0.40

1.1

—

(3023419) Bacteria identified in Sputum by Culture

206

1086

1.07

0.39

2.5

2.6

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

362

1942

1.05

0.39

1.2

u/ml

4.8

3.7

0.67

141

809

(3011544) Albumin [Mass/volume] in Pleural fluid

1.37

0.39

1.3

1.1

g/l

19.8

15.1

—

(44806071)

190

0.83

0.39

1.1

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

0.70

0.38

1.1

1.3

—

(40759057) Lysozyme [Mass/volume] in Cerebral spinal fluid

1.36

0.38

1.0

1.1

mg/l

0.0

0.69

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

130

1.21

0.38

1.0

u/ml

0.6

0.0

0.44

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

0.69

0.38

1.0

1.2

ug/g

114.6

152.0

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

314

1.13

0.38

1.0

1.1

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

1.33

0.38

2.8

3.1

—

(3013293) Extractable nuclear Ab [Presence] in Serum

277

1.14

0.38

1.6

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

140

0.80

0.37

1.1

1.0

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

553

3000

1.04

0.37

1.3

mg/l

523.0

488.0

0.42

529

2859

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

0.75

0.37

1.1

1.0

u/ml

5.7

12.8

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

141

1.20

0.37

1.2

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

347

1.12

0.37

4.5

4.2

mg/l

2915.0

519.3

0.39

242

(3004616) Nuclear Ab [Presence] in Serum

338

1814

1.05

0.37

1.4

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

580

3151

1.04

0.37

1.2

—

(3042517) Benzodiazepines panel - Urine

121

0.79

0.36

1.3

2.2

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

1.41

0.35

1.0

1.1

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

128

779

0.93

0.35

1.2

1.1

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

322

1.12

0.35

1.3

1.4

40.3

49.6

1.11

276

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

137

1.19

0.35

6.5

4.7

ug/min

43.7

34.3

0.26

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

195

1.16

0.34

1.5

1.7

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

792

4334

1.03

0.34

1.6

1.8

g/l

1.2

2.10

752

4117

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

404

2184

1.04

0.34

1.1

u/ml

3.2

2.7

0.30

190

1126

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

388

1.10

0.33

2.0

2.1

ug/min

46.7

28.7

0.33

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

442

1.10

0.33

1.2

1.1

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

264

0.87

0.33

1.1

1.2

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

111

676

0.92

0.32

1.2

1.4

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.37

0.32

1.0

—

(3020491) Glucose [Moles/volume] in Blood

137

827

0.93

0.32

2.2

1.7

mmol/l

6.9

6.5

0.80

583

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

113

589

1.08

0.32

1.1

—

(4133840)

281

0.88

0.31

1.2

1.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

120

727

0.93

0.31

1.2

1.1

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.22

0.31

2.0

2.1

—

(40762887) Creatinine [Moles/volume] in Blood

1.31

0.31

1.3

1.2

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

488

2655

1.04

0.31

1.2

mmol/l

3.6

3.7

0.29

460

2481

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

139

732

1.07

0.31

1.1

u/ml

9.8

6.9

0.48

133

(44806420)

229

1.13

0.30

2.1

2.3

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

136

716

1.07

0.30

1.4

1.3

umol/l

3.4

4.5

3.69

126

657

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

189

1006

1.06

0.30

1.5

1.6

—

(4027681)

159

842

1.06

0.30

1.3

1.2

—

(3003181) Sodium [Moles/volume] in Urine

317

1711

1.04

0.30

1.3

1.4

mmol/l

59.1

62.9

0.94

256

1354

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

1.25

0.30

1.0

1.3

ml/s/173m2

1.2

2.7

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

2599

14840

0.99

0.29

1.6

1.8

—

(3050794) Legionella sp Ab [Presence] in Serum

0.77

0.29

1.0

1.2

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

2043

11334

1.02

0.29

1.2

iu/ml

137.9

153.3

1.03

773

4656

(3041806) Other cells [#/volume] in Blood by Manual count

225

0.88

0.28

1.7

1.5

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

213

0.87

0.28

1.2

1.3

—

(3000285) Sodium [Moles/volume] in Blood

130

1.17

0.28

1.1

1.2

—

(3020874) Milk IgE Ab [Units/volume] in Serum

164

977

0.95

0.27

1.0

1.1

u/ml

0.5

3.5

0.73

244

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

110

0.82

0.27

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

178

950

1.06

0.27

1.2

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

285

1.11

0.27

1.1

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

112

589

1.07

0.27

1.2

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

164

0.86

0.27

1.0

u/ml

0.1

0.2

0.67

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.65

0.27

1.0

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

0.80

0.26

1.2

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

114

601

1.07

0.26

1.1

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

297

1.10

0.26

1.0

mg/g

8.1

5.5

1.09

277

(3034988) Calcium [Moles/volume] in Capillary blood

179

1.13

0.25

2.5

1.8

mmol/l

1.2

0.83

170

(3008116) Ketones [Moles/volume] in Urine by Test strip

193

0.88

0.25

1.2

1.4

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1.31

0.25

1.0

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

207

1113

1.05

0.25

1.3

1.2

u/ml

76.8

63.4

0.26

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

120

719

0.94

0.25

1.1

1.2

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

159

849

1.06

0.25

1.1

ratio

1.1

0.24

287

(3008295) Osmolality of Serum or Plasma

179

959

1.05

0.25

1.4

1.5

mosm/kgh2o

279.1

278.1

0.28

142

731

(3009677) Dengue virus Ab [Presence] in Serum

0.70

0.25

1.0

1.1

—

(3022689) Creatine [Moles/volume] in Urine

336

1.09

0.24

1.3

1.6

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

180

1.13

0.24

1.2

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

207

1115

1.05

0.24

1.3

1.2

u/ml

48.5

49.0

0.01

(3045177) Copper [Moles/volume] in Urine

1.34

0.24

1.4

1.0

umol/l

1.1

0.2

—

(3009871) Measles virus Ab [Titer] in Serum

508

0.93

0.23

1.8

1.7

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

218

1.11

0.23

1.1

u/ml

0.7

0.2

0.35

135

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

397

0.92

0.23

2.3

2.4

au/ml

176.4

166.5

0.05

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

490

0.93

0.23

1.0

—

(3023420) DNA double strand Ab [Units/volume] in Serum

278

1624

0.96

0.23

1.5

1.6

iu/ml

45.9

36.9

0.19

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

485

1.07

0.22

1.8

2.0

umol/l

146.9

134.6

0.15

267

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

0.00

0.22

0.0

1.0

—

(3040794) Aluminum [Moles/volume] in Urine

0.00

0.22

0.0

1.0

—

(3006498) Trichoderma viride IgE Ab [Units/volume] in Serum

0.00

0.22

0.0

1.0

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

128

683

1.06

0.22

1.2

titre

44.3

50.3

—

(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine

0.00

0.21

0.0

1.0

—

19.6

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

364

1990

1.03

0.21

1.2

u/ml

3.1

3.4

0.08

101

670

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

399

1.07

0.21

2.1

2.3

umol/l

51.9

52.2

0.03

322

(3038026) Centromere Ab [Units/volume] in Serum

211

1142

1.04

0.21

1.3

1.2

u/ml

40.4

60.9

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

1.25

0.20

1.0

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

130

0.87

0.20

1.0

u/ml

0.3

2.1

0.54

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

1.23

0.20

1.0

1.3

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

297

1.08

0.19

1.1

1.2

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

259

1.09

0.19

3.8

2.6

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

259

1.09

0.19

3.8

2.7

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

281

1.08

0.19

1.1

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

1.23

0.19

1.0

1.1

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

129

0.87

0.19

1.0

u/ml

0.0

0.5

0.89

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

456

0.94

0.19

1.7

1.8

mg/l

8.8

9.7

0.56

364

(3036071) Salmonella sp Ab [Titer] in Serum

407

1.07

0.19

1.1

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1558

8885

0.99

0.18

1.5

1.4

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

119

704

0.95

0.18

1.0

ng/l

39.2

47.2

0.83

494

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

768

4249

1.02

0.18

1.7

1.8

g/l

0.2

0.87

726

4030

(3044009) aPTT.lupus sensitive (LA screen)

117

0.87

0.18

1.2

—

(3051101) Glucose [Moles/volume] in Cord blood

182

0.90

0.18

5.0

4.9

—

(3004775) Volume in Urine collected for unspecified duration

110

652

0.95

0.18

2.2

2.3

710.5

617.6

1.31

492

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

105

0.86

0.18

1.2

1.5

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

152

0.89

0.18

1.1

—

(3045716) Anion gap in Serum or Plasma

392

1.06

0.17

3.6

2.4

mmol/l

9.2

9.1

0.14

280

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

0.70

0.17

2.2

1.2

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

164

960

0.96

0.17

1.4

1.3

nmol/l

1.1

1.3

0.99

135

775

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

431

1.06

0.17

1.1

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

0.85

0.16

1.4

2.1

umol/l

46.3

49.7

0.26

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

430

0.94

0.16

2.8

2.9

mg/l

7.9

7.8

0.04

336

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

736

4213

0.98

0.16

1.1

u/ml

3.0

5.4

1.38

566

(3019174) dRVVT (LA screen)

121

0.88

0.15

1.2

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

119

699

0.96

0.15

1.0

ng/l

784.0

749.0

0.40

483

(42529582) MDA5 Ab [Presence] in Serum by Line blot

312

1.07

0.15

1.1

1.2

—

(3013637) Mi-2 Ab [Presence] in Serum

312

1.07

0.15

1.1

1.2

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

312

1.07

0.15

1.1

1.2

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

312

1.07

0.15

1.1

1.2

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

0.80

0.15

1.6

2.8

—

20.5

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

249

0.93

0.15

1.2

1.1

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

247

1354

1.03

0.14

1.1

93.8

94.9

0.26

233

1266

(3019768) Coxiella burnetii Ab [Presence] in Serum

0.83

0.14

1.0

1.1

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

407

1.05

0.14

1.0

1.1

u/ml

2.8

1.0

0.37

211

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

219

0.93

0.13

1.1

1.0

u/ml

0.2

0.5

0.28

149

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

112

606

1.04

0.13

1.9

1.7

u/field

2.1

0.00

409

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

671

3724

1.02

0.13

1.6

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

143

0.91

0.13

1.1

umol/24h

1.6

0.13

143

(3042733) HLA Ab [Presence] in Serum

292

1.06

0.13

5.3

5.2

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

513

1.04

0.13

1.3

1.2

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

137

798

0.97

0.12

1.4

1.3

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

122

663

1.04

0.12

1.1

1.2

u/ml

26.9

7.1

0.56

(3006653) Thiamine [Moles/volume] in Blood

109

591

1.04

0.12

1.4

1.5

nmol/l

137.6

132.2

0.68

109

591

(43055514) Macroprolactin [Presence] in Serum or Plasma

339

0.95

0.12

1.2

1.5

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

192

1111

0.97

0.12

2.4

2.5

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

1.14

0.12

1.1

1.0

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

277

1.06

0.11

1.1

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

129

1.09

0.11

1.0

u/ml

0.0

0.55

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

151

1.08

0.11

1.2

—

(3000060) B lymphocytes [#/volume] in Blood

286

0.95

0.11

1.7

2.0

e6/l

165.9

171.5

0.05

169

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

967

5392

1.01

0.11

1.7

mg/l

3.2

3.3

0.27

693

3843

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

968

5508

0.99

0.11

1.8

2.0

u/l

5409.2

4462.3

0.40

316

2154

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

2275

12895

0.99

0.11

1.8

1.6

—

(3028717) Thiamine [Mass/volume] in Blood

135

1.08

0.10

1.2

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

194

1067

1.02

0.10

1.3

1.2

u/ml

2.6

8.7

—

(3014891) Appearance of Pleural fluid

0.87

0.10

1.8

1.6

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

119

1.09

0.10

1.0

u/ml

0.1

0.8

0.89

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

1.13

0.10

1.0

1.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

150

823

1.03

0.10

1.8

1.9

—

(40757373) Influenza virus identified in Isolate

163

1.07

0.10

1.5

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

204

0.94

0.10

1.6

2.7

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

124

719

0.97

0.10

1.3

1.6

promille

1.2

1.3

0.17

545

(3029612) Listeria sp Ab [Titer] in Serum

1.08

0.10

1.0

1.3

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

107

584

1.03

0.09

1.1

miu/ml

1641.7

1519.2

0.46

107

584

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

119

690

0.97

0.09

1.0

ng/l

658.7

333.0

0.57

495

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

1.04

0.09

4.2

5.0

mmol/l

0.2

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

480

2669

1.01

0.09

1.3

e6/l

25.5

32.6

0.36

377

2090

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

0.89

0.09

1.1

1.0

u/ml

0.2

0.4

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

0.89

0.09

1.0

1.1

—

(3008860) Bordetella pertussis IgM Ab [Presence] in Serum

1.13

0.09

1.3

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

285

1579

1.02

0.09

1.2

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1275

7131

1.01

0.09

1.5

—

(3046861) Legionella sp Ag [Presence] in Urine

1.06

0.09

1.0

1.1

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

146

803

1.02

0.08

1.3

1.5

u/ml

16.4

23.3

1.70

166

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

419

1.04

0.08

1.3

1.2

—

(3008898) HLA-B27 [Presence]

1004

5612

1.01

0.08

1.1

—

(3011325) HIV 1+2 Ab [Presence] in Serum

0.82

0.08

1.2

1.0

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

353

1.04

0.08

1.1

—

(3019150) Specific gravity of Urine by Refractometry

4640

26216

1.00

0.07

4.2

4.1

kg/l

1.0

0.87

717

4003

(44816559) Phosphatidylethanol [Mass/volume] in Blood

355

1974

1.01

0.07

1.2

1.3

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

526

1.03

0.07

1.5

1.4

pmol/l

14.3

0.03

445

(3015956) Eosinophils/100 leukocytes in Blood by Manual count

1.02

0.07

1.1

1.3

1.7

2.3

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

592

3365

0.99

0.07

1.3

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

0.90

0.07

1.5

1.2

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

0.89

0.06

1.0

1.1

—

(3041672) Baker's yeast Ab [Presence] in Serum

0.89

0.06

1.0

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

479

2673

1.01

0.06

1.3

1.4

e6/l

1583.5

1856.9

0.14

397

2197

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

434

0.97

0.06

4.5

4.2

u/ml

311.7

1689.9

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

0.92

0.06

1.2

1.1

u/l

9.9

11.8

0.17

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

0.91

0.05

1.0

—

27.8

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

689

3904

0.99

0.04

1.6

iu/ml

0.1

5.3

0.61

138

757

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

159

0.96

0.04

2.2

1.3

51.4

50.5

0.03

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

210

1196

0.99

0.04

1.1

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

210

1196

0.99

0.04

1.1

1.2

—

(3052592) Norovirus Ag [Presence] in Stool

190

1.04

0.04

1.4

1.2

—

(3010937) Rubella virus Ab [Presence] in Serum

0.93

0.04

1.1

—

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

0.94

0.04

1.0

u/ml

0.0

0.5

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

312

0.97

0.04

1.0

1.1

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

168

1.04

0.04

1.2

1.3

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

164

913

1.01

0.03

1.0

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

375

1.02

0.03

1.6

au/ml

123.4

144.0

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

375

1.02

0.03

1.3

1.2

42.5

19.3

1.33

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

317

0.98

0.03

1.1

1.2

—

(4034850)

749

4233

1.00

0.02

7.7

8.2

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

371

1.02

0.02

1.1

—

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

163

0.97

0.02

1.7

mg/l

1.2

1.6

1.43

135

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

211

1197

0.99

0.02

1.1

1.2

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

104

579

1.01

0.02

1.5

3.9

4.3

0.08

116

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

293

1.02

0.02

1.2

1.1

—

(3015183) Erythrocyte sedimentation rate

138

784

0.99

0.02

1.1

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

208

1179

0.99

0.02

1.1

1.2

—

(3023410) Appearance of Cerebral spinal fluid

219

1227

1.01

0.01

1.3

1.5

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

0.95

0.01

1.1

u/ml

1.4

3.8

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

209

1182

1.00

0.01

1.1

1.2

—

(3044242) Glucose [Moles/volume] in Arterial blood

353

0.99

0.00

1.6

2.0

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

299

1688

1.00

0.00

1.5

—

(3001729) Color of Synovial fluid

0.99

0.00

1.9

1.7

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

145

1.01

0.00

2.6

2.3

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

213

1.00

0.00

1.1

1.0

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

284

1.01

0.00

1.1

umol/24h

0.5

0.6

0.74

143

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

203

1.00

0.00

1.0

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

203

1.00

0.00

1.0

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

203

1.00

0.00

1.0

1.1

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

132

1.02

0.00

1.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

116

652

1.00

0.00

1.2

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

167

942

1.00

0.00

1.0

u/ml

0.9

1.7

0.48

192

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

101

568

1.00

0.00

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

209

1180

1.00

0.00

1.1

1.2

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

364

2051

1.00

0.00

2.3

2.4

ug/min

72.6

63.2

0.18

204

1182

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

174

1.00

0.00

1.9

1.6

mmol/l

1.2

1.39

164

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

174

1.00

0.00

1.5

1.6

nmol/l

480008.8

238854.4

0.30

139

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

139

1.01

0.00

1.2

1.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

381

2145

1.00

0.00

1.5

—

(3000492) Spirometry study

2109

11883

1.00

0.00

1.4

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

272

0.99

0.00

1.2

1.1

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

181

1020

1.00

0.00

1.2

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

1.04

0.00

1.2

1.0

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

157

1.00

0.00

1.0

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

291

1641

1.00

0.00

1.1

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

108

0.99

0.00

1.1

nmol/l

10.8

13.4

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

358

1.01

0.00

4.2

4.1

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

0.99

0.00

1.8

2.2

—

(3016038) Potassium [Moles/volume] in Urine

117

661

1.00

0.00

1.1

1.2

mmol/l

34.1

31.9

0.47

548

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

303

1.00

0.00

1.1

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

0.98

0.00

1.0

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

0.88

0.00

1.2

1.0

—

(3002568) Complement factor B [Mass/volume] in Serum or Plasma

0.96

0.00

1.1

1.0

g/l

0.2

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

1.01

0.00

1.2

1.0

—

(3042628) Porphyrins [Moles/volume] in Urine

0.00

0.0

1.0

—

(3025830) Chlamydophila pneumoniae IgM Ab [Units/volume] in Serum

0.00

0.0

1.2

—

(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

0.94

0.00

1.3

1.1

u/l

357.5

390.7

—

(3016072) Theophylline [Mass/volume] in Serum or Plasma

0.00

0.0

1.2

—

(40761593) Coagulation factor VIII Ab [Presence] in Platelet poor plasma by Immunoassay

0.00

0.0

1.4

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

0.91

0.00

1.0

1.1

—

(3013851) Stachybotrys chartarum IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3014171) Thiocyanate [Moles/volume] in Serum or Plasma

0.00

0.0

1.4

—

190.4

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: CD2_BENIGN_LEIOMYOMA_UTERI_EXALLC – Leiomyoma of uterus

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Leiomyoma of uterus

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints